{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":184,"total_is_capped":false,"direct_labels_cover":2,"predictions_cover":184,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"43ac0f224e9c","filters":{"venue":"Future Oncology"}},"results":[{"id":"W2339030197","doi":"10.2217/fon-2016-0130","title":"ROBUST: Lenalidomide-R-Chop Versus Placebo-R-Chop in Previously Untreated Abc-Type Diffuse Large B-Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lenalidomide; Medicine; CHOP; Diffuse large B-cell lymphoma; Internal medicine; Clinical endpoint; Lymphoma; Oncology; Placebo; Pathology; Clinical trial; Multiple myeloma","authors":[{"name":"Grzegorz S. Nowakowski","is_ca":false},{"name":"Annalisa Chiappella","is_ca":false},{"name":"Thomas E. Witzig","is_ca":false},{"name":"Michele Spina","is_ca":false},{"name":"Randy D. Gascoyne","is_ca":true},{"name":"Lei Zhang","is_ca":false},{"name":"Jocelyne Flament","is_ca":false},{"name":"Jacqueline Repici","is_ca":false},{"name":"Umberto Vitolo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02435570999588384,"gpt":0.2834791903245364,"spread":0.2591234803286526,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002122811,0.001181582,0.00293958,0.0005737134,0.0002451964,0.001158629,0.001139843,0.001385029,0.007148249],"category_scores_gemma":[0.002344669,0.0004731581,0.001495212,0.0003961491,0.000875504,0.001449771,0.000611354,0.002650557,0.001018482],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007595051,"about_ca_system_score_gemma":0.0007379442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003968953,"about_ca_topic_score_gemma":0.001111914,"domain_scores_codex":[0.9987412,0.0007146709,0.0001099414,0.0002040083,0.000103003,0.0001272955],"domain_scores_gemma":[0.9991472,0.0002688771,0.0002406035,0.00008394474,0.00004795377,0.0002114414],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9627337,0.005127855,0.0001781786,0.0005327622,0.0007463896,0.00002431513,0.00001993772,0.0004502978,0.003874574,0.0001282871,0.0007584888,0.02542521],"study_design_scores_gemma":[0.7479,0.2407354,0.002744972,0.0001327979,0.001293357,0.00009049536,0.00004644187,0.001429668,0.002509303,0.0005971168,0.002478083,0.00004225022],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9624131,0.02084069,0.001324046,0.001478251,0.001463921,0.002898732,0.002895189,0.0004713967,0.006214578],"genre_scores_gemma":[0.9855956,0.003529038,0.002589193,0.001082917,0.0004894703,0.001945387,0.001558225,0.00005288075,0.003157292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007148249,"threshold_uncertainty_score":0.0239132,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2896248377","doi":"10.2217/fon-2018-0711","title":"Sequential treatment with afatinib and osimertinib in patients with <i>EGFR</i> mutation-positive non-small-cell lung cancer: an observational study","year":2018,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Osimertinib; Afatinib; Medicine; T790M; Observational study; Internal medicine; Lung cancer; Oncology; Clinical trial; Chemotherapy; Retrospective cohort study; Cancer; Epidermal growth factor receptor; Erlotinib; Gefitinib","authors":[{"name":"Maximilian J. Hochmair","is_ca":false},{"name":"Alessandro Morabito","is_ca":false},{"name":"Desirée Hao","is_ca":true},{"name":"Cheng‐Ta Yang","is_ca":false},{"name":"Ross A. Soo","is_ca":false},{"name":"James Chih‐Hsin Yang","is_ca":false},{"name":"Rasim Gucalp","is_ca":false},{"name":"Balázs Halmos","is_ca":false},{"name":"Lara Wang","is_ca":false},{"name":"Amanda Golembesky","is_ca":false},{"name":"Angela Märten","is_ca":false},{"name":"Tanja Čufer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0245710663428718,"gpt":0.3572036998636381,"spread":0.3326326335207663,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001262819,0.0002941237,0.0007757883,0.000276681,0.0004414408,0.0006376894,0.0004555931,0.0006039002,0.001043121],"category_scores_gemma":[0.0030712,0.0003342187,0.001268067,0.0007372824,0.0003743744,0.000648835,0.0004132219,0.0008573834,0.000204692],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007863685,"about_ca_system_score_gemma":0.0009309798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002410362,"about_ca_topic_score_gemma":0.003456602,"domain_scores_codex":[0.998546,0.0005196744,0.0002078593,0.0004037608,0.0001738317,0.0001489633],"domain_scores_gemma":[0.9956334,0.0005867803,0.002986247,0.000215192,0.0001619278,0.0004165281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008949026,0.0007538478,0.9842307,0.0001058414,0.0007968577,0.0001307019,0.00008802415,0.0001531172,0.0005807885,0.00002485659,0.000338182,0.003848165],"study_design_scores_gemma":[0.002551131,0.00859578,0.9840639,0.00004961205,0.000803503,0.001101681,0.0003185069,0.0009662518,0.0004013967,0.00008568042,0.001037741,0.00002496462],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989421,0.0003829449,0.0000711131,0.00004425736,0.000008290745,0.00003268251,0.0003314134,0.000002114869,0.0001851054],"genre_scores_gemma":[0.9988225,0.0001823194,0.0001149168,0.00007837918,0.00002993011,0.00004060902,0.0006698684,0.000001618096,0.00005985871],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002410362,"threshold_uncertainty_score":0.006678462,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4366236771","doi":"10.2217/fon-2022-1196","title":"Design of SERENA-6, a phase III switching trial of camizestrant in <i>ESR1</i> -mutant breast cancer during first-line treatment","year":2023,"lang":"en","type":"article","venue":"Future Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"AstraZeneca","keywords":"Medicine; Mutant; Breast cancer; Oncology; Cancer; Line (geometry); Internal medicine; Cancer research; Genetics; Biology; Gene","authors":[{"name":"Nicholas C. Turner","is_ca":false},{"name":"Cynthia Huang Bartlett","is_ca":false},{"name":"Kevin Kalinsky","is_ca":false},{"name":"Massimo Cristofanilli","is_ca":false},{"name":"Giampaolo Bianchini","is_ca":false},{"name":"Stephen Chia","is_ca":true},{"name":"Hiroji Iwata","is_ca":false},{"name":"Wolfgang Janni","is_ca":false},{"name":"X. Cynthia","is_ca":false},{"name":"Erica L. Mayer","is_ca":false},{"name":"Yeon Hee Park","is_ca":false},{"name":"Stephen B. Fox","is_ca":false},{"name":"Xiaochun Liu","is_ca":false},{"name":"Sasha McClain","is_ca":false},{"name":"François‐Clément Bidard","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03019315399695848,"gpt":0.354143198096221,"spread":0.3239500440992625,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002446686,0.001793274,0.00257803,0.0004484964,0.0005112399,0.00152763,0.0009277398,0.001533314,0.007970481],"category_scores_gemma":[0.001583478,0.0007021169,0.00124993,0.0003779494,0.001098124,0.001123439,0.000457088,0.003757961,0.001745276],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008857214,"about_ca_system_score_gemma":0.002263509,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006227182,"about_ca_topic_score_gemma":0.0018446,"domain_scores_codex":[0.9991552,0.0003337228,0.00005025447,0.0001840411,0.0000715116,0.0002053275],"domain_scores_gemma":[0.9991316,0.0001331881,0.0001322432,0.00007081424,0.00005644312,0.0004757429],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.9385995,0.02749463,0.0009024368,0.0004197065,0.0005917721,0.00007725199,0.00007016515,0.001316046,0.006379207,0.0004206679,0.001314819,0.02241381],"study_design_scores_gemma":[0.7526728,0.2397185,0.001720122,0.00003630237,0.000389321,0.00005393332,0.00003207103,0.0009453252,0.0009113112,0.000572752,0.002925639,0.00002186885],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9150139,0.003652948,0.003725565,0.001288972,0.001618599,0.05840068,0.003429234,0.000354581,0.01251549],"genre_scores_gemma":[0.9244323,0.002292856,0.005450339,0.002892994,0.0006606455,0.05138829,0.00222017,0.0000796276,0.01058265],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.007970481,"threshold_uncertainty_score":0.0266639,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3012293314","doi":"10.2217/fon-2020-0044","title":"MIRROS: A Randomized, Placebo-Controlled, Phase III Trial of Cytarabine ± Idasanutlin in Relapsed or Refractory Acute Myeloid Leukemia","year":2020,"lang":"en","type":"article","venue":"Future Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Cytarabine; Myeloid leukemia; Refractory (planetary science); Internal medicine; Placebo; Oncology; Randomized controlled trial; Myeloid; Pathology","authors":[{"name":"Pau Montesinos","is_ca":false},{"name":"Benjamin M. Beckermann","is_ca":false},{"name":"Olivier Catalani","is_ca":false},{"name":"Jordi Esteve","is_ca":false},{"name":"Katia Gamel","is_ca":false},{"name":"Marina Konopleva","is_ca":false},{"name":"Giovanni Martinelli","is_ca":false},{"name":"Annabelle Monnet","is_ca":false},{"name":"Cristina Papayannidis","is_ca":false},{"name":"Aaron Park","is_ca":true},{"name":"Christian Récher","is_ca":false},{"name":"Rebeca Rodríguez‐Veiga","is_ca":false},{"name":"Christoph Röllig","is_ca":false},{"name":"Norbert Vey","is_ca":false},{"name":"Andrew H. Wei","is_ca":false},{"name":"Sung‐Soo Yoon","is_ca":false},{"name":"Pierre Fenaux","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02589568544120383,"gpt":0.3477053238999175,"spread":0.3218096384587137,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009617419,0.00149047,0.001469584,0.0003453459,0.0003560416,0.00079337,0.0008405037,0.0009919306,0.0113618],"category_scores_gemma":[0.001132271,0.0003865864,0.0008603024,0.0003162213,0.0008905072,0.0007563694,0.0003662106,0.00241661,0.001363563],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005575138,"about_ca_system_score_gemma":0.001397046,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006476213,"about_ca_topic_score_gemma":0.0026937,"domain_scores_codex":[0.999718,0.0001497219,0.00001419497,0.00004877015,0.00003163079,0.00003774913],"domain_scores_gemma":[0.9996445,0.00006361559,0.00009647247,0.00002593408,0.00002485534,0.0001444452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9496425,0.006523974,0.0003986801,0.001287827,0.0005726442,0.0000526955,0.00005924822,0.0004159806,0.005374798,0.0007006515,0.003711427,0.03125966],"study_design_scores_gemma":[0.9601614,0.03622997,0.0005606842,0.00005026519,0.0001398697,0.00003422558,0.00002005009,0.0002433295,0.0003780822,0.0002024939,0.00197206,0.000007576731],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9541463,0.008008415,0.001622454,0.001931558,0.001607566,0.01671763,0.004040163,0.0005471767,0.01137885],"genre_scores_gemma":[0.9388293,0.00873191,0.006341456,0.003093362,0.001081513,0.0178668,0.004810153,0.00009818102,0.01914723],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0113618,"threshold_uncertainty_score":0.03800905,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3134027539","doi":"10.2217/fon-2020-1264","title":"CDK4/6 Inhibitors in HR+/HER2- Advanced/metastatic Breast Cancer: A Systematic Literature Review of Real-World Evidence Studies","year":2021,"lang":"en","type":"review","venue":"Future Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Medicine; Oncology; Metastatic breast cancer; Internal medicine; Breast cancer; Trastuzumab; Real world evidence; Cancer; Gynecology","authors":[{"name":"Nadia Harbeck","is_ca":false},{"name":"Meaghan Bartlett","is_ca":true},{"name":"Dean Spurden","is_ca":false},{"name":"Becky Hooper","is_ca":true},{"name":"Lin Zhan","is_ca":false},{"name":"Emily Rosta","is_ca":true},{"name":"Chris Cameron","is_ca":true},{"name":"Debanjali Mitra","is_ca":false},{"name":"Anna Zhou","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06187251663254414,"gpt":0.4556644636025236,"spread":0.3937919469699794,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007340411,0.001449362,0.005773337,0.009160914,0.0004943937,0.002419225,0.001536605,0.001400316,0.005747071],"category_scores_gemma":[0.03286784,0.0008141308,0.006541298,0.009029248,0.0006625541,0.001786761,0.001288583,0.001228321,0.0004706068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00246552,"about_ca_system_score_gemma":0.009783769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004872321,"about_ca_topic_score_gemma":0.01608275,"domain_scores_codex":[0.9948791,0.001653386,0.0019505,0.000445806,0.0008783992,0.0001928678],"domain_scores_gemma":[0.973565,0.02052725,0.003615899,0.0002965658,0.001803113,0.0001922094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001673034,0.00001415497,0.0006066737,0.941159,0.006300121,0.00007837306,0.0001000819,0.0001065371,0.0001600634,0.0002704507,0.001887832,0.0491494],"study_design_scores_gemma":[0.0001531145,0.0001492244,0.003113284,0.9004779,0.06225792,0.0003776192,0.0001950554,0.00007308031,0.0001847563,0.0004471387,0.03254054,0.00003041775],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004074461,0.9985728,0.00009213619,0.0002269751,0.00006415277,0.00008961833,0.0003016892,0.000004392953,0.0002407378],"genre_scores_gemma":[0.00452737,0.994484,0.0002835496,0.0003024248,0.00004946285,0.0001274497,0.0001709465,0.000002541095,0.0000522282],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009160914,"threshold_uncertainty_score":0.03882027,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2138368669","doi":"10.2217/fon.15.251","title":"Current State of Biomarkers in Ovarian Cancer Prognosis","year":2015,"lang":"en","type":"review","venue":"Future Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Ovarian cancer; Carboplatin; Paclitaxel; Tumor microenvironment; Disease; Drug resistance; Oncology; Chemotherapy; Cancer; Serous fluid; Internal medicine; Bioinformatics; Cisplatin; Biology","authors":[{"name":"Katrina Au","is_ca":true},{"name":"Juliana Alves Josahkian","is_ca":false},{"name":"Julie‐Ann Francis","is_ca":true},{"name":"Jeremy A. Squire","is_ca":false},{"name":"Madhuri Koti","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07496433028108566,"gpt":0.4302141523516914,"spread":0.3552498220706057,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001673243,0.0007784397,0.001462757,0.002363073,0.0002553331,0.001371361,0.000979054,0.0009540716,0.00252765],"category_scores_gemma":[0.003479016,0.0002464736,0.0006889763,0.00251738,0.0006011509,0.001479493,0.0008370612,0.001580112,0.001185408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008403636,"about_ca_system_score_gemma":0.001273293,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001600954,"about_ca_topic_score_gemma":0.001882034,"domain_scores_codex":[0.9994789,0.000144534,0.00009357052,0.00007540849,0.0001680131,0.00003964391],"domain_scores_gemma":[0.9984968,0.0008128856,0.0002004854,0.00003631355,0.0004004522,0.0000531537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006242992,0.00002860955,0.00118813,0.007512554,0.00009861372,0.0000986695,0.00005275574,0.0002975382,0.0004666713,0.00226607,0.0191898,0.9687382],"study_design_scores_gemma":[0.00002015122,0.0001494995,0.004091285,0.01183923,0.0004015676,0.001562191,0.0001701377,0.0004205997,0.0009408179,0.00624567,0.9741061,0.00005277678],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001457328,0.9981773,0.0002036771,0.0006314674,0.0001887112,0.000004401078,0.00003357867,0.000008171281,0.0006070563],"genre_scores_gemma":[0.002435748,0.9959483,0.0004683705,0.0003417995,0.0003284509,0.00001161381,0.00007880003,0.000002307815,0.0003847493],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00252765,"threshold_uncertainty_score":0.008849025,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3082658746","doi":"10.2217/fon-2020-0740","title":"Sequential Afatinib and Osimertinib in Patients with <i>EGFR</i> Mutation-Positive Non-Small-Cell Lung Cancer: Final Analysis of the GioTag Study","year":2020,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Boehringer Ingelheim","keywords":"Afatinib; Osimertinib; Medicine; Lung cancer; Internal medicine; Oncology; T790M; Clinical trial; Cancer; Adenocarcinoma; Erlotinib; Epidermal growth factor receptor","authors":[{"name":"Maximilian J. Hochmair","is_ca":false},{"name":"Alessandro Morabito","is_ca":false},{"name":"Desirée Hao","is_ca":true},{"name":"Cheng‐Ta Yang","is_ca":false},{"name":"Ross A. Soo","is_ca":false},{"name":"James Chih‐Hsin Yang","is_ca":false},{"name":"Rasim Gucalp","is_ca":false},{"name":"Balázs Halmos","is_ca":false},{"name":"Angela Märten","is_ca":false},{"name":"Tanja Čufer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01026167357481095,"gpt":0.3128247802196673,"spread":0.3025631066448563,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002368081,0.0005167819,0.001008301,0.0003557856,0.0002199771,0.0009163434,0.0004255683,0.0004738676,0.0009140117],"category_scores_gemma":[0.001484398,0.0002328733,0.002236446,0.00095761,0.0003703412,0.0005044439,0.0005094641,0.0007834727,0.0001668103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009222961,"about_ca_system_score_gemma":0.001051516,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002257982,"about_ca_topic_score_gemma":0.00835734,"domain_scores_codex":[0.9991353,0.0003876228,0.00007527884,0.0001620452,0.0001239392,0.0001157601],"domain_scores_gemma":[0.9988652,0.0002376991,0.0004243897,0.0001249266,0.00008802368,0.0002597801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.108805,0.000564069,0.8276692,0.0007095492,0.009942994,0.0003424173,0.0002356479,0.001424467,0.003801826,0.0001756499,0.003379095,0.04295009],"study_design_scores_gemma":[0.0184868,0.01084722,0.9564753,0.0001122485,0.006771218,0.0007327101,0.0002509178,0.001105318,0.0008231138,0.0003181447,0.004027954,0.00004903503],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943067,0.003158758,0.0001117055,0.0001754537,0.00001935893,0.00009617263,0.001455448,0.000009362241,0.0006669314],"genre_scores_gemma":[0.9962908,0.0005907025,0.000183732,0.0001604805,0.0000245845,0.00006901472,0.002527304,0.000004754605,0.0001486554],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002368081,"threshold_uncertainty_score":0.01252377,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068549807","doi":"10.2217/fon.14.208","title":"Dovitinib (CHIR258, TKI258): Structure, Development and Preclinical and Clinical Activity","year":2015,"lang":"en","type":"article","venue":"Future Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Sorafenib; Platelet-derived growth factor receptor; Tyrosine-kinase inhibitor; Receptor; Pharmacology; VEGF receptors; Receptor tyrosine kinase; Cancer research; Tyrosine kinase; Oncology; Cancer; Internal medicine; Growth factor; Hepatocellular carcinoma","authors":[{"name":"Camillo Porta","is_ca":true},{"name":"Palma Giglione","is_ca":true},{"name":"Wanda Liguigli","is_ca":false},{"name":"Chiara Paglino","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06228528774817588,"gpt":0.404677689405457,"spread":0.3423924016572811,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000300846,0.0005335044,0.0003728699,0.0007356208,0.0002229612,0.0007530744,0.0003283889,0.0004104806,0.001547826],"category_scores_gemma":[0.000185899,0.00019511,0.000270699,0.000462953,0.0002929567,0.0003197256,0.0001934657,0.000876261,0.0009375741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005557357,"about_ca_system_score_gemma":0.0005752921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008886047,"about_ca_topic_score_gemma":0.001367213,"domain_scores_codex":[0.9999273,0.00000841813,0.000005697942,0.00001225942,0.00002796266,0.00001831906],"domain_scores_gemma":[0.9999204,0.000006660291,0.00001906227,0.000005245991,0.00001137445,0.00003737598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005672671,0.002222339,0.003528823,0.001134095,0.00008339888,0.0009105755,0.0000975294,0.003421505,0.5855078,0.002100059,0.004000704,0.3913204],"study_design_scores_gemma":[0.006802401,0.05219039,0.05417448,0.0004383724,0.0006260932,0.01630851,0.0001916635,0.008511693,0.5677533,0.001882587,0.2909036,0.0002169576],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7825915,0.1734888,0.007043937,0.002312484,0.000307658,0.0009268157,0.003441417,0.0002841529,0.02960333],"genre_scores_gemma":[0.9167252,0.06079647,0.005463931,0.0006237958,0.0001804002,0.0002219853,0.006421812,0.00004429679,0.009522125],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.001547826,"threshold_uncertainty_score":0.005177975,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4292884011","doi":"10.2217/fon-2022-0595","title":"HERIZON-GEA-01: Zanidatamab + chemo ± tislelizumab for 1L treatment of HER2-positive gastroesophageal adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Future Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Zymeworks (Canada); Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Trastuzumab; Internal medicine; Chemotherapy; Oncology; Gastroesophageal Junction; Monoclonal antibody; Cancer; Adenocarcinoma; Antibody; Immunology; Breast cancer","authors":[{"name":"Josep Tabernero","is_ca":false},{"name":"Lin Shen","is_ca":false},{"name":"Elena Elimova","is_ca":true},{"name":"Geoffrey Y. Ku","is_ca":false},{"name":"Tianshu Liu","is_ca":false},{"name":"Kohei Shitara","is_ca":false},{"name":"Xiao Lin","is_ca":false},{"name":"Lisa Boyken","is_ca":true},{"name":"Huiyan Li","is_ca":false},{"name":"Jonathan Grim","is_ca":true},{"name":"Jaffer A. Ajani","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01669934964258832,"gpt":0.2941696805263527,"spread":0.2774703308837643,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001198645,0.0005391653,0.001212089,0.0004947397,0.0003454499,0.0008938258,0.0007193228,0.0008617095,0.003783883],"category_scores_gemma":[0.0004678228,0.0003112205,0.0008631262,0.000347078,0.0007408186,0.0007880672,0.0004282858,0.002227673,0.000593023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009471893,"about_ca_system_score_gemma":0.001441494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007270395,"about_ca_topic_score_gemma":0.003951804,"domain_scores_codex":[0.9995878,0.0001571409,0.00003012662,0.00008247671,0.00005157143,0.00009083772],"domain_scores_gemma":[0.9997397,0.0000280716,0.00006295976,0.00001774548,0.00001405637,0.0001374394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6499197,0.04973606,0.004449927,0.001657971,0.001271162,0.0001908281,0.0002088878,0.002365812,0.06059912,0.001327585,0.002835097,0.2254379],"study_design_scores_gemma":[0.6007178,0.363463,0.01046298,0.0001529552,0.0007725217,0.0002994942,0.00009868766,0.001413688,0.0106792,0.0005525467,0.01133883,0.00004810368],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821665,0.003887843,0.001090262,0.0006654187,0.0002339925,0.006717302,0.001055004,0.0001158831,0.004067704],"genre_scores_gemma":[0.9855123,0.002279846,0.003464306,0.0009624198,0.0001001945,0.004049222,0.0009383786,0.00002631341,0.002666925],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003783883,"threshold_uncertainty_score":0.01265836,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2795150236","doi":"10.2217/fon-2018-0121","title":"Accelerating Drug Development in Pediatric Cancer: A Novel Phase I Study Design of Venetoclax in Relapsed/Refractory Malignancies","year":2018,"lang":"en","type":"article","venue":"Future Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Celgene; Sanofi; Genentech; Ariad Pharmaceuticals; Amgen","keywords":"Venetoclax; Medicine; Clinical trial; Refractory (planetary science); Oncology; Internal medicine; Drug development; Chronic lymphocytic leukemia; Chemotherapy; Cancer; Drug; Leukemia; Pharmacology","authors":[{"name":"Andrew E. Place","is_ca":false},{"name":"Kelly C. Goldsmith","is_ca":false},{"name":"Jean‐Pierre Bourquin","is_ca":false},{"name":"Mignon L. Loh","is_ca":false},{"name":"Lia Gore","is_ca":false},{"name":"Daniel A. Morgenstern","is_ca":true},{"name":"Yeshwant D. Sanzgiri","is_ca":false},{"name":"David Hoffman","is_ca":false},{"name":"Ying Zhou","is_ca":false},{"name":"Jeremy A. Ross","is_ca":false},{"name":"Betty Prine","is_ca":false},{"name":"Mohamad Shebley","is_ca":false},{"name":"Megan McNamee","is_ca":false},{"name":"Thalia A. Farazi","is_ca":false},{"name":"Su Young Kim","is_ca":false},{"name":"Maria Verdugo","is_ca":false},{"name":"L. Leanne Lash-Fleming","is_ca":false},{"name":"C. Michel Zwaan","is_ca":false},{"name":"Josef Vormoor","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06121352229830328,"gpt":0.3801271580229051,"spread":0.3189136357246018,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003242641,0.0008893522,0.001259406,0.0003606791,0.0004438518,0.001108071,0.0005893068,0.001031783,0.005998425],"category_scores_gemma":[0.001682878,0.0004160709,0.001162951,0.0004326412,0.0006206364,0.0008368762,0.0004483633,0.002762962,0.000821829],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007372733,"about_ca_system_score_gemma":0.003861179,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005278023,"about_ca_topic_score_gemma":0.002086293,"domain_scores_codex":[0.9991274,0.000490867,0.00004861627,0.0001378416,0.00006843633,0.0001268014],"domain_scores_gemma":[0.9991386,0.000156318,0.0001713426,0.0001157777,0.0001129106,0.0003049766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4542416,0.1039446,0.01087568,0.003235728,0.002057294,0.0008259684,0.0009983063,0.007787378,0.120026,0.007509308,0.01504633,0.2734517],"study_design_scores_gemma":[0.3559322,0.5670363,0.006833122,0.0002261878,0.001623434,0.0007592523,0.0001594658,0.004338278,0.01563365,0.001842959,0.04554956,0.00006563222],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9145941,0.005193626,0.01286507,0.00221817,0.0007316656,0.0527349,0.003163842,0.0002114494,0.008287278],"genre_scores_gemma":[0.8583454,0.007488488,0.05101257,0.003035917,0.0005072664,0.0684733,0.002257173,0.00009792967,0.008781956],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005998425,"threshold_uncertainty_score":0.02006674,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3032832010","doi":"10.2217/fon-2020-0184","title":"Pembrolizumab Given Concomitantly with Chemoradiation and as Maintenance Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: KEYNOTE-412","year":2020,"lang":"en","type":"article","venue":"Future Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"Rosetrees Trust; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Pembrolizumab; Head and neck squamous-cell carcinoma; Head and neck; Oncology; Basal cell; Internal medicine; Head and neck cancer; Radiation therapy; Surgery; Immunotherapy; Cancer","authors":[{"name":"Jean‐Pascal Machiels","is_ca":false},{"name":"Yungan Tao","is_ca":false},{"name":"Barbara Burtness","is_ca":false},{"name":"Makoto Tahara","is_ca":false},{"name":"Lisa Licitra","is_ca":false},{"name":"Danny Rischin","is_ca":false},{"name":"John Waldron","is_ca":true},{"name":"Christian Simon","is_ca":false},{"name":"Vincent Grégoire","is_ca":false},{"name":"Kevin J. Harrington","is_ca":false},{"name":"Gustavo Vasconcelos Alves","is_ca":false},{"name":"Iane Pinto Figueiredo Lima","is_ca":false},{"name":"Y. Pointreau","is_ca":false},{"name":"Brett Hughes","is_ca":false},{"name":"Sercan Aksoy","is_ca":false},{"name":"Marcin Hetnał","is_ca":false},{"name":"Joy Yang Ge","is_ca":false},{"name":"Holly Brown","is_ca":false},{"name":"Jonathan D. Cheng","is_ca":false},{"name":"Behzad Bidadi","is_ca":false},{"name":"Lillian L. Siu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0139099776184559,"gpt":0.2772550983325816,"spread":0.2633451207141257,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002465941,0.001003389,0.00190735,0.000629299,0.0009925588,0.001116838,0.001173501,0.002164349,0.01135982],"category_scores_gemma":[0.001076578,0.0007137447,0.001132708,0.0007804415,0.001353364,0.001691241,0.0006511497,0.00330539,0.001767435],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001199267,"about_ca_system_score_gemma":0.002654459,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001131738,"about_ca_topic_score_gemma":0.003641553,"domain_scores_codex":[0.9988177,0.0005121503,0.0001210687,0.0002164112,0.0001342132,0.0001983877],"domain_scores_gemma":[0.9993472,0.00008433695,0.0001377611,0.00009165383,0.00004667311,0.0002924727],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7913667,0.0545518,0.001392737,0.002043235,0.000745345,0.0001224176,0.0001459871,0.0004984577,0.03363847,0.0008587958,0.003659224,0.1109768],"study_design_scores_gemma":[0.6580005,0.3234338,0.003553895,0.0001194304,0.0004354506,0.0001370483,0.00003491123,0.0002376614,0.005120021,0.0002310321,0.00866989,0.0000263477],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9279079,0.01244976,0.002152125,0.001614528,0.001054939,0.03961981,0.003148211,0.0003063067,0.01174637],"genre_scores_gemma":[0.9579143,0.004711063,0.004265546,0.001717599,0.0006233492,0.0206852,0.001771873,0.00004794668,0.008263057],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01135982,"threshold_uncertainty_score":0.03800237,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385442656","doi":"10.2217/fon-2023-0228","title":"TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer","year":2023,"lang":"en","type":"article","venue":"Future Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Oncology; Breast cancer; Triple-negative breast cancer; Internal medicine; Triple negative; Cancer","authors":[{"name":"Rebecca Dent","is_ca":false},{"name":"David W. Cescon","is_ca":true},{"name":"Thomas Bachelot","is_ca":false},{"name":"Kyung Hae Jung","is_ca":false},{"name":"Zhi‐Ming Shao","is_ca":false},{"name":"Shigehira Saji","is_ca":false},{"name":"Tiffany A. Traina","is_ca":false},{"name":"Petra Vuković","is_ca":false},{"name":"Darlington Mapiye","is_ca":false},{"name":"Micah J. Maxwell","is_ca":false},{"name":"Peter Schmid","is_ca":false},{"name":"Javier Cortés","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05001610890154408,"gpt":0.3967505803952925,"spread":0.3467344714937484,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004994231,0.0002262736,0.0005057554,0.0002407592,0.0001680763,0.0003850249,0.0002782328,0.0004234742,0.006069934],"category_scores_gemma":[0.0003059845,0.0001046385,0.0002381867,0.0002308509,0.0001705389,0.0003136571,0.0002284147,0.0007323634,0.0009758603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005430272,"about_ca_system_score_gemma":0.000509131,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005545153,"about_ca_topic_score_gemma":0.003224759,"domain_scores_codex":[0.9998803,0.00004762668,0.000006608851,0.00001936449,0.00002155565,0.00002449611],"domain_scores_gemma":[0.9998659,0.00001890091,0.00002848057,0.00001048867,0.000009174658,0.00006707131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1040957,0.005467332,0.008752756,0.001020604,0.0004362042,0.0004571206,0.000117882,0.001789385,0.05861811,0.001137658,0.02794396,0.7901633],"study_design_scores_gemma":[0.2420598,0.27443,0.1217721,0.0005737792,0.001075182,0.006416044,0.000218027,0.006091602,0.06132457,0.002463569,0.2834886,0.00008660383],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9354998,0.0325469,0.001028084,0.00467254,0.0003387079,0.001384368,0.002289355,0.000310404,0.02192994],"genre_scores_gemma":[0.9706687,0.01120256,0.001548848,0.001848235,0.0001641292,0.0005402117,0.002717321,0.00002962993,0.01128036],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006069934,"threshold_uncertainty_score":0.02030593,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122558264","doi":"10.2217/fon.12.3","title":"The Current Role of Circulating Tumor Cells in the Diagnosis and Management of Bone Metastases in Advanced Prostate Cancer","year":2012,"lang":"en","type":"review","venue":"Future Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Circulating tumor cell; Management of prostate cancer; Oncology; Cancer; Prostate-specific antigen; Prostate; Internal medicine; Disease; Disease monitoring; Metastasis","authors":[{"name":"Fred Saad","is_ca":true},{"name":"Klaus Pantel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05575054018666093,"gpt":0.4170604696478369,"spread":0.361309929461176,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009297662,0.0006537159,0.001569878,0.001875342,0.0002256273,0.0008433159,0.0009237948,0.001069781,0.00193213],"category_scores_gemma":[0.001209977,0.0002483186,0.0004845808,0.002029833,0.00053826,0.001242114,0.0005368174,0.001425172,0.001432228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005162164,"about_ca_system_score_gemma":0.0009752723,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001275349,"about_ca_topic_score_gemma":0.001951527,"domain_scores_codex":[0.9997204,0.00006154964,0.00005335177,0.00004382232,0.00010227,0.00001857988],"domain_scores_gemma":[0.9993344,0.000342447,0.00009292558,0.00001669478,0.0001751992,0.00003825314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005933084,0.00004487813,0.0002000566,0.01419131,0.00005587262,0.0001313676,0.00004872469,0.0002539223,0.0009709988,0.001141204,0.009999551,0.9729029],"study_design_scores_gemma":[0.00003373233,0.0002602086,0.002448258,0.008426523,0.0002870326,0.002848731,0.0001531078,0.0002000023,0.0008225085,0.0024363,0.982043,0.00004059814],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001016277,0.9991872,0.00009237567,0.0002078627,0.00006897826,0.000002404751,0.000007738866,0.00000328771,0.000328566],"genre_scores_gemma":[0.0004739064,0.9990276,0.0001651224,0.0001019904,0.00008305182,0.000003477699,0.00001271963,8.078358e-7,0.0001313475],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00193213,"threshold_uncertainty_score":0.006463647,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3107254051","doi":"10.2217/fon-2020-0655","title":"Dostarlimab in the Treatment of Recurrent or Primary Advanced Endometrial Cancer","year":2020,"lang":"en","type":"review","venue":"Future Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Microsatellite instability; Endometrial cancer; Medicine; DNA mismatch repair; Oncology; Internal medicine; Immune checkpoint; Immune system; Cancer; Cancer research; Immunotherapy; Microsatellite; Immunology; Gene; Genetics; Biology","authors":[{"name":"Lawrence Kasherman","is_ca":true},{"name":"Soha Ahrari","is_ca":true},{"name":"Stéphanie Lheureux","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08592308035728641,"gpt":0.4281559395685617,"spread":0.3422328592112753,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002822253,0.0004301518,0.0008559345,0.001146704,0.0001533849,0.0004747739,0.0004214885,0.0004028318,0.003828004],"category_scores_gemma":[0.0003671373,0.0001375859,0.0005491431,0.0009889271,0.0001417545,0.0004330329,0.0003674627,0.0007890896,0.0009585028],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002960542,"about_ca_system_score_gemma":0.0005502664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007205908,"about_ca_topic_score_gemma":0.00201793,"domain_scores_codex":[0.9999027,0.00002267859,0.00001784739,0.00001725779,0.00003089176,0.000008552141],"domain_scores_gemma":[0.9998989,0.00005407074,0.00001881766,0.000002152227,0.0000193636,0.000006728651],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001294813,0.00005173686,0.00009403397,0.03184815,0.0001704265,0.0001083083,0.00004353972,0.0002591735,0.001336115,0.00098246,0.01069899,0.9542776],"study_design_scores_gemma":[0.0001033087,0.0003639091,0.001585105,0.01558286,0.0008077766,0.001827246,0.0000740802,0.0002020303,0.00088991,0.001232364,0.9773107,0.00002050469],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002125881,0.9988999,0.0000482263,0.00008677714,0.00005936957,0.000005671805,0.00001778953,0.00000422128,0.0006653552],"genre_scores_gemma":[0.001127252,0.9982215,0.0001007307,0.0001266678,0.0000398559,0.000006850073,0.00003131367,9.223193e-7,0.0003449041],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003828004,"threshold_uncertainty_score":0.01280588,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1996531785","doi":"10.2217/fon.09.26","title":"Role of The<i>MTHFR</i>Polymorphisms in Cancer Risk Modification and Treatment","year":2009,"lang":"en","type":"review","venue":"Future Oncology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada Research Chairs; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Methylenetetrahydrofolate reductase; Single-nucleotide polymorphism; Medicine; Pharmacogenetics; Pharmacology; Antimetabolite; Cancer; Methotrexate; Bioinformatics; Cancer research; Allele; Internal medicine; Genetics; Biology; Genotype; Gene","authors":[{"name":"Young‐In Kim","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05384394065183835,"gpt":0.4075805005562327,"spread":0.3537365599043944,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001781799,0.000245318,0.0008463153,0.0005614488,0.000248629,0.0008559655,0.0005193471,0.001194219,0.001988905],"category_scores_gemma":[0.007093634,0.0001313974,0.001055268,0.001097791,0.000373127,0.0002958161,0.000310287,0.001070036,0.0003521746],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008721004,"about_ca_system_score_gemma":0.0009143901,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004452812,"about_ca_topic_score_gemma":0.002646961,"domain_scores_codex":[0.998363,0.000851777,0.0001264979,0.0002321878,0.0003095148,0.000117031],"domain_scores_gemma":[0.9975562,0.0009619875,0.000824136,0.0001434627,0.0002861383,0.00022815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002392734,0.0007300379,0.3132302,0.001998309,0.003796299,0.0005843462,0.0001900957,0.00199651,0.003309511,0.005479427,0.01551378,0.6507788],"study_design_scores_gemma":[0.0007629595,0.002208773,0.8326066,0.002977795,0.005964813,0.001732185,0.0002415521,0.004893309,0.002985137,0.01181101,0.1336861,0.0001298495],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1836396,0.7343199,0.005579494,0.0508243,0.001506624,0.0001356745,0.002039582,0.0001706643,0.02178423],"genre_scores_gemma":[0.7676429,0.2127082,0.004352089,0.007087023,0.002940287,0.0001634177,0.001422831,0.00004115955,0.003642106],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004452812,"threshold_uncertainty_score":0.009423196,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2166859022","doi":"10.2217/fon.09.157","title":"Potential Use of Ultrasound for the Detection of Cell Changes in Cancer Treatment","year":2009,"lang":"en","type":"review","venue":"Future Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":47,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Toronto Metropolitan University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Ultrasound; Oncology; Cancer; Internal medicine; Radiology","authors":[{"name":"Michael C. Kolios","is_ca":true},{"name":"Gregory J. Czarnota","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03504508620806288,"gpt":0.3067117270932862,"spread":0.2716666408852233,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008484413,0.0009576014,0.001208265,0.002430603,0.0003392085,0.0009534095,0.0009572575,0.001634785,0.00315855],"category_scores_gemma":[0.0007177363,0.0004388418,0.0005283157,0.002037172,0.0008137705,0.001549741,0.0007094709,0.001565779,0.002331286],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006079453,"about_ca_system_score_gemma":0.0007718946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00132765,"about_ca_topic_score_gemma":0.002574441,"domain_scores_codex":[0.9997709,0.0000374181,0.00002050065,0.00004415212,0.0001050512,0.00002202609],"domain_scores_gemma":[0.9995245,0.0002704177,0.00005350108,0.00001231804,0.0001151105,0.00002424713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008467196,0.0001518974,0.0003004156,0.008461965,0.0000662646,0.0004396539,0.0001117576,0.0007306892,0.01977283,0.004633371,0.01088861,0.9543579],"study_design_scores_gemma":[0.00003081955,0.0002448509,0.001399716,0.002100195,0.000114975,0.003405514,0.0001576797,0.0005635694,0.01341434,0.003358742,0.9751478,0.0000617835],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003941701,0.9959195,0.0008833918,0.0002599948,0.0001850002,0.000008940146,0.00001147295,0.000009345643,0.002328146],"genre_scores_gemma":[0.002327538,0.994366,0.0009577075,0.0002138447,0.0001911513,0.00001204191,0.00002641462,0.000002795161,0.001902354],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00315855,"threshold_uncertainty_score":0.01056635,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2159471993","doi":"10.2217/14796694.2.6.765","title":"Erbb Receptors and Epithelial-Cadherin–Catenin Complex In Human Carcinomas","year":2006,"lang":"en","type":"review","venue":"Future Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Cadherin; Medicine; Receptor; Catenin; ErbB; Cancer research; Signal transduction; Internal medicine; Biology; Cell biology; Cell; Wnt signaling pathway; Genetics","authors":[{"name":"Amber Yasmeen","is_ca":true},{"name":"Tarek A. Bismar","is_ca":true},{"name":"Ala‐Eddin Al Moustafa","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1385490509996071,"gpt":0.4622853322673678,"spread":0.3237362812677608,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003924675,0.0007840191,0.001233797,0.002150624,0.0002398243,0.000639352,0.0006916624,0.0009325564,0.003226017],"category_scores_gemma":[0.0003521936,0.0002639,0.0003266017,0.002261094,0.0003516268,0.001049428,0.0004372517,0.001128261,0.002703248],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007003917,"about_ca_system_score_gemma":0.000724763,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001255229,"about_ca_topic_score_gemma":0.002138363,"domain_scores_codex":[0.9998389,0.00002410737,0.00002015567,0.00002748909,0.00007376329,0.00001551142],"domain_scores_gemma":[0.9998713,0.00004433559,0.00001937067,0.000004472508,0.00004626627,0.00001420356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007897299,0.00008425517,0.0002656855,0.008208491,0.00006056005,0.0005267335,0.00006483633,0.0003095526,0.002837632,0.002284185,0.03105154,0.9542276],"study_design_scores_gemma":[0.00001884167,0.00008382271,0.001295116,0.001670706,0.00007639914,0.003554938,0.00005471959,0.00006423852,0.0006820993,0.001223699,0.9912617,0.00001369411],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001109184,0.9988189,0.00006479162,0.000106667,0.0001009555,0.000002674597,0.000005616542,0.000005520377,0.0007839612],"genre_scores_gemma":[0.0006000468,0.9982187,0.0001060763,0.00009011283,0.00009679772,0.000002924396,0.00001499429,6.715752e-7,0.0008695211],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003226017,"threshold_uncertainty_score":0.01079208,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387950784","doi":"10.2217/fon-2023-0526","title":"TALAPRO-3 Clinical Trial Protocol: Phase III Study of Talazoparib Plus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer","year":2023,"lang":"en","type":"article","venue":"Future Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Astellas Pharma; Pfizer","keywords":"Enzalutamide; Medicine; Prostate cancer; Clinical endpoint; Internal medicine; Oncology; Olaparib; Placebo; Androgen deprivation therapy; Clinical trial; Androgen receptor; Cancer; Poly ADP ribose polymerase; Gene; Pathology; Biology; Polymerase","authors":[{"name":"Neeraj Agarwal","is_ca":false},{"name":"Fred Saad","is_ca":true},{"name":"Arun Azad","is_ca":false},{"name":"Joaquı́n Mateo","is_ca":false},{"name":"Nobuaki Matsubara","is_ca":false},{"name":"Neal D. Shore","is_ca":false},{"name":"Jayeta Chakrabarti","is_ca":false},{"name":"Hsiang-Chun Chen","is_ca":false},{"name":"Silvana Lanzalone","is_ca":false},{"name":"Alexander Niyazov","is_ca":false},{"name":"Karim Fizazi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1308447482002217,"gpt":0.5230714336123913,"spread":0.3922266854121696,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004813264,0.002590483,0.002989067,0.0005472091,0.001318495,0.002224885,0.002555102,0.003789631,0.0460971],"category_scores_gemma":[0.003421827,0.001262765,0.001282789,0.0008318623,0.001151897,0.001797839,0.0007957834,0.005912058,0.0114277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001989493,"about_ca_system_score_gemma":0.007968955,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001577103,"about_ca_topic_score_gemma":0.007986011,"domain_scores_codex":[0.9987458,0.0005851883,0.00008562968,0.0001896762,0.0001664831,0.0002272238],"domain_scores_gemma":[0.9982899,0.0001836861,0.0003131664,0.0001824043,0.0002616319,0.0007691637],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8297661,0.02079126,0.00148242,0.004027182,0.001096017,0.0003197918,0.0002657404,0.002089241,0.009668626,0.003353112,0.07942329,0.04771734],"study_design_scores_gemma":[0.9038705,0.04077351,0.002804447,0.0003114513,0.0002850964,0.0001605442,0.00005447998,0.001323032,0.001023597,0.001393777,0.04795435,0.00004514775],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.1372633,0.007553805,0.008758244,0.005512243,0.003165196,0.7267165,0.05447811,0.001717829,0.05483481],"genre_scores_gemma":[0.199969,0.005629554,0.01356596,0.0113687,0.00126382,0.6851442,0.02945233,0.000290845,0.05331558],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.0460971,"threshold_uncertainty_score":0.1542102,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4291019728","doi":"10.2217/fon-2022-0484","title":"Phase III MANIFEST-2: Pelabresib + Ruxolitinib vs Placebo + Ruxolitinib in JAK Inhibitor Treatment-Naive Myelofibrosis","year":2022,"lang":"en","type":"article","venue":"Future Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Medical Research Council; Rosetrees Trust; Cancer Research UK","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Myeloproliferative neoplasm; Internal medicine; Placebo; Clinical trial; Oncology; Extramedullary hematopoiesis; Bone marrow; Haematopoiesis; Pathology; Stem cell","authors":[{"name":"Claire Harrison","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Aaron T. Gerds","is_ca":false},{"name":"Raajit K. Rampal","is_ca":false},{"name":"Srđan Verstovšek","is_ca":false},{"name":"Moshe Talpaz","is_ca":false},{"name":"Jean‐Jacques Kiladjian","is_ca":false},{"name":"Ruben A. Mesa","is_ca":false},{"name":"Andrew Kuykendall","is_ca":false},{"name":"Alessandro M. Vannucchi","is_ca":false},{"name":"Francesca Palandri","is_ca":false},{"name":"Sebastian Grosicki","is_ca":false},{"name":"Timothy Devos","is_ca":false},{"name":"Éric Jourdan","is_ca":false},{"name":"Mariëlle J. Wondergem","is_ca":false},{"name":"Haifa Kathrin Al‐Ali","is_ca":false},{"name":"Veronika Buxhofer‐Ausch","is_ca":false},{"name":"Alberto Álvarez‐Larrán","is_ca":false},{"name":"Andrea Patriarca","is_ca":false},{"name":"Marina Kremyanskaya","is_ca":false},{"name":"Adam J. Mead","is_ca":false},{"name":"Sanjay Akhani","is_ca":false},{"name":"Yuri Sheikine","is_ca":false},{"name":"Gozde Colak","is_ca":false},{"name":"John Mascarenhas","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02084345738915811,"gpt":0.3262002128301859,"spread":0.3053567554410278,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002428198,0.002081517,0.002649994,0.0005147458,0.0004293114,0.001557684,0.001338837,0.001991296,0.008080728],"category_scores_gemma":[0.001424909,0.0007302813,0.001819538,0.000407183,0.001225254,0.001351708,0.0005286559,0.003737227,0.001462661],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008967637,"about_ca_system_score_gemma":0.001370436,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006859622,"about_ca_topic_score_gemma":0.001604049,"domain_scores_codex":[0.9994524,0.0002834822,0.00003054643,0.00008064493,0.00004468433,0.0001082984],"domain_scores_gemma":[0.9992734,0.0001411428,0.0001924816,0.00007382977,0.00006807112,0.000251201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9263062,0.03241385,0.000644197,0.001042583,0.000750591,0.00006389369,0.00008437909,0.0007983129,0.01054135,0.0003161995,0.002736674,0.02430181],"study_design_scores_gemma":[0.8411897,0.1543238,0.001595927,0.00004654545,0.0002088391,0.00004933694,0.00003540174,0.0003627182,0.0009032508,0.0001680026,0.001101308,0.00001500452],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9662924,0.007972532,0.001454409,0.001384486,0.0008733924,0.0126647,0.00428293,0.0004683224,0.004606822],"genre_scores_gemma":[0.9575067,0.00539423,0.003709649,0.002702853,0.0009683568,0.01501786,0.005535427,0.000108706,0.009056184],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008080728,"threshold_uncertainty_score":0.02703273,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3119071615","doi":"10.2217/fon-2020-1048","title":"MOMENTUM: Momelotinib Vs Danazol in Patients with Myelofibrosis Previously Treated with JAKi Who Are Symptomatic and Anemic","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sierra Wireless (Canada); Princess Margaret Cancer Centre","funders":"Medical Research Council; Cancer Research UK","keywords":"Myelofibrosis; Medicine; Ruxolitinib; Anemia; Constitutional symptoms; Internal medicine; Bone marrow","authors":[{"name":"Srđan Verstovšek","is_ca":false},{"name":"Chih‐Cheng Chen","is_ca":false},{"name":"Miklós Egyed","is_ca":false},{"name":"Martin Ellis","is_ca":false},{"name":"María Laura Fox","is_ca":false},{"name":"Yeow Tee Goh","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Claire Harrison","is_ca":false},{"name":"Jean‐Jacques Kiladjian","is_ca":false},{"name":"Mihaela Lazaroiu","is_ca":false},{"name":"Adam J. Mead","is_ca":false},{"name":"Donal P. McLornan","is_ca":false},{"name":"Mary Frances McMullin","is_ca":false},{"name":"Stephen T. Oh","is_ca":false},{"name":"Andrew C. Perkins","is_ca":false},{"name":"Uwe Platzbecker","is_ca":false},{"name":"Christof Scheid","is_ca":false},{"name":"Alessandro M. Vannucchi","is_ca":false},{"name":"Sung‐Soo Yoon","is_ca":false},{"name":"Mark Kowalski","is_ca":true},{"name":"Ruben A. Mesa","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005068712736830131,"gpt":0.2304273460770635,"spread":0.2253586333402334,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004766438,0.0003743355,0.0007980262,0.0002449034,0.0002069362,0.0006967856,0.0002727763,0.0005354765,0.005209791],"category_scores_gemma":[0.0007691896,0.0001467887,0.0005509733,0.0002479659,0.0002422915,0.0007091829,0.0002641575,0.001040882,0.0005219782],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004530507,"about_ca_system_score_gemma":0.0005994413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000609983,"about_ca_topic_score_gemma":0.002878738,"domain_scores_codex":[0.999871,0.00005488818,0.000009262752,0.00001816602,0.00001418028,0.00003246712],"domain_scores_gemma":[0.999698,0.00008842231,0.00006529409,0.00001403491,0.0000117623,0.0001224199],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7058152,0.00597989,0.007282899,0.0006394524,0.0009334337,0.000366398,0.000112032,0.001685954,0.008617202,0.0009348555,0.008935201,0.2586975],"study_design_scores_gemma":[0.515525,0.382346,0.05706986,0.0004481776,0.001938027,0.001460069,0.0003152648,0.004482788,0.003430029,0.001915281,0.03098643,0.00008291694],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9657882,0.01715935,0.0003584767,0.002500455,0.0006126672,0.0004034455,0.00125608,0.0001081774,0.01181324],"genre_scores_gemma":[0.9903147,0.003953429,0.0005145404,0.001193054,0.0002834387,0.0002548452,0.0008238246,0.00000993734,0.002652246],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005209791,"threshold_uncertainty_score":0.01742852,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2059728548","doi":"10.2217/14796694.3.5.575","title":"Role of Dead Box 1 In Retinoblastoma and Neuroblastoma","year":2007,"lang":"en","type":"review","venue":"Future Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Retinoblastoma; Neuroblastoma; Cancer research; Medicine; Pediatric cancer; Gene; Cancer; Biology; Genetics; Internal medicine","authors":[{"name":"Roseline Godbout","is_ca":true},{"name":"Lei Li","is_ca":true},{"name":"Rong‐Zong Liu","is_ca":true},{"name":"Ken Roy","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03436796280175208,"gpt":0.3918929967397098,"spread":0.3575250339379578,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039498,0.0006492037,0.001071662,0.001868882,0.0003114553,0.0006772598,0.0006663688,0.0008870182,0.002430785],"category_scores_gemma":[0.0003134783,0.0002771544,0.0002918967,0.001618339,0.0004897836,0.001092275,0.0005129094,0.001147359,0.002229631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007013638,"about_ca_system_score_gemma":0.0007763415,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001128476,"about_ca_topic_score_gemma":0.002047404,"domain_scores_codex":[0.9998926,0.0000167141,0.00001574924,0.00002318384,0.00004104317,0.00001076622],"domain_scores_gemma":[0.9998854,0.00004438953,0.00002363746,0.000004156335,0.00002876705,0.00001367543],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00008495593,0.00006475278,0.0003053577,0.008204679,0.00005152774,0.0007243981,0.00009349066,0.0005590497,0.005852156,0.005340936,0.01895951,0.9597592],"study_design_scores_gemma":[0.00001674851,0.00006533098,0.001070119,0.001382935,0.00004918249,0.003187826,0.0000678631,0.00008751261,0.00155335,0.002606165,0.9898971,0.00001596962],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002157538,0.9984422,0.0001187071,0.0001430786,0.00008937532,0.0000023358,0.000008823544,0.000005898271,0.0009736747],"genre_scores_gemma":[0.0009216496,0.997764,0.0001991925,0.00009228659,0.00007758448,0.00000383433,0.00002055808,9.520664e-7,0.0009199605],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002430785,"threshold_uncertainty_score":0.008131802,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205173478","doi":"10.2217/fon-2021-1096","title":"A Phase III, Randomized, Open-Label Study (CONTACT-02) of Cabozantinib Plus Atezolizumab Versus Second Novel Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer","year":2022,"lang":"en","type":"article","venue":"Future Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Exelixis","keywords":"Cabozantinib; Medicine; Atezolizumab; Prostate cancer; Enzalutamide; Oncology; Internal medicine; Clinical trial; Cancer; Nivolumab; Immunotherapy; Androgen receptor","authors":[{"name":"Neeraj Agarwal","is_ca":false},{"name":"Arun Azad","is_ca":false},{"name":"Joan Carles","is_ca":false},{"name":"Simon Chowdhury","is_ca":false},{"name":"Bradley A. McGregor","is_ca":false},{"name":"Axel S. Merseburger","is_ca":false},{"name":"Stéphane Oudard","is_ca":false},{"name":"Fred Saad","is_ca":true},{"name":"Andrey Soares","is_ca":false},{"name":"Fawzi Benzaghou","is_ca":false},{"name":"Yannick Kerloëguen","is_ca":false},{"name":"Akiko Kimura","is_ca":false},{"name":"Nehal Mohamed","is_ca":false},{"name":"Ashok Panneerselvam","is_ca":false},{"name":"Fong Wang","is_ca":false},{"name":"Sumanta K. Pal","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05788647460081912,"gpt":0.3914232047436411,"spread":0.333536730142822,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001850247,0.002006486,0.002021509,0.0004706626,0.0005845237,0.001362285,0.001069281,0.002259512,0.01012396],"category_scores_gemma":[0.001637846,0.0007293473,0.001776587,0.0005427977,0.001375562,0.001401473,0.0004156049,0.003813041,0.001704914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001200338,"about_ca_system_score_gemma":0.002192958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001470034,"about_ca_topic_score_gemma":0.00522629,"domain_scores_codex":[0.9993261,0.0003441733,0.00002762191,0.0001313951,0.00005226073,0.0001183544],"domain_scores_gemma":[0.9988949,0.0002084822,0.0002015924,0.00009632146,0.00007742194,0.0005213667],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9545907,0.02089841,0.001017218,0.0003894042,0.0007345037,0.00006777638,0.00008249916,0.0004296893,0.004922209,0.0002237426,0.002653964,0.01398984],"study_design_scores_gemma":[0.9361807,0.06120115,0.001038862,0.00001036267,0.0001188397,0.00003189552,0.00001724452,0.0002345321,0.0002656077,0.0001233952,0.0007682048,0.000009122461],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9671072,0.002447207,0.001148893,0.001652423,0.0009003226,0.01505865,0.004853846,0.0003188671,0.006512623],"genre_scores_gemma":[0.9584429,0.001895856,0.003926696,0.003606891,0.0009649604,0.01619295,0.005185696,0.00008140095,0.009702659],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01012396,"threshold_uncertainty_score":0.03386807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3134403963","doi":"10.2217/fon-2020-1269","title":"Belantamab Mafodotin in Combination with Novel Agents in Relapsed/refractory Multiple Myeloma: DREAMM-5 Study Design","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Oncology; Refractory (planetary science); Carfilzomib; Internal medicine; Pomalidomide","authors":[{"name":"Ajay K. Nooka","is_ca":false},{"name":"Katja Weisel","is_ca":false},{"name":"Niels W.C.J. van de Donk","is_ca":false},{"name":"David Routledge","is_ca":false},{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"Kevin Song","is_ca":true},{"name":"Hang Quach","is_ca":false},{"name":"Natalie S. Callander","is_ca":false},{"name":"Monique C. Minnema","is_ca":false},{"name":"Suzanne Trudel","is_ca":true},{"name":"Nicola Jackson","is_ca":false},{"name":"Christoph M. Ahlers","is_ca":false},{"name":"Ellie Im","is_ca":false},{"name":"Shinta Cheng","is_ca":false},{"name":"Lon Smith","is_ca":false},{"name":"Geraldine Ferron‐Brady","is_ca":false},{"name":"Maria Brouch","is_ca":false},{"name":"Rocío Montes de","is_ca":false},{"name":"Sofia Paul","is_ca":false},{"name":"Beata Holkova","is_ca":false},{"name":"Ira Gupta","is_ca":false},{"name":"Brandon E. Kremer","is_ca":false},{"name":"Paul G. Richardson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.050819269986887,"gpt":0.3395705788726691,"spread":0.2887513088857821,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003426611,0.00164897,0.00250744,0.0004756929,0.0004223557,0.001450643,0.001217195,0.001300296,0.007481374],"category_scores_gemma":[0.001287652,0.0006650438,0.002395519,0.0005394521,0.0008881476,0.001173793,0.0007051152,0.002945262,0.001383377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001298187,"about_ca_system_score_gemma":0.002636024,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007694847,"about_ca_topic_score_gemma":0.002191164,"domain_scores_codex":[0.9990453,0.0004749883,0.00006803351,0.0001600528,0.00008624653,0.0001653898],"domain_scores_gemma":[0.9994212,0.00009058746,0.0001037945,0.00004709159,0.00005983818,0.0002775547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.8676599,0.04257989,0.003681403,0.002890722,0.003028228,0.0002758574,0.0002399078,0.002276829,0.01233567,0.001460642,0.004352382,0.05921859],"study_design_scores_gemma":[0.6029377,0.3716927,0.003726651,0.0001625718,0.002334418,0.0001945132,0.00009644531,0.001592036,0.002140101,0.0007245847,0.01435354,0.00004481113],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9309916,0.01302273,0.003118447,0.001826993,0.0008321297,0.03393439,0.003829325,0.0001808813,0.01226355],"genre_scores_gemma":[0.9290661,0.007395224,0.00758937,0.003465269,0.0008668336,0.0366725,0.003334475,0.00006218814,0.01154811],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.007481374,"threshold_uncertainty_score":0.02502769,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2123883580","doi":"10.1517/14796694.1.1.125","title":"Therapeutic implications of DNA methylation","year":2005,"lang":"en","type":"review","venue":"Future Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"DNA methylation; Epigenome; Epigenetics; Reprogramming; Epigenomics; Biology; Cancer research; Gene silencing; Cancer epigenetics; Genetics; Gene; Gene expression","authors":[{"name":"Moshe Szyf","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04446095228224609,"gpt":0.3873035522682998,"spread":0.3428425999860537,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005445289,0.0006107093,0.0008573532,0.001147196,0.0002782126,0.0006917907,0.0008157059,0.001370521,0.003773393],"category_scores_gemma":[0.0005149932,0.0001699605,0.0003318644,0.000714449,0.0006853156,0.0008800233,0.0006240918,0.001602339,0.001957379],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008197313,"about_ca_system_score_gemma":0.0005611387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008130253,"about_ca_topic_score_gemma":0.001890584,"domain_scores_codex":[0.9998397,0.00004172055,0.00001211343,0.0000323407,0.0000568125,0.00001726224],"domain_scores_gemma":[0.9998635,0.00006464955,0.00001765757,0.000008111882,0.00003064901,0.00001549064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007892007,0.00005858033,0.0002221061,0.004132364,0.00005875764,0.0005495904,0.0001100387,0.0006241303,0.01055017,0.01657589,0.02345844,0.943581],"study_design_scores_gemma":[0.00002252824,0.00008905656,0.0006149171,0.0008588525,0.00003445461,0.002653875,0.00005183093,0.0001505847,0.003688236,0.006580577,0.9852401,0.00001497599],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004054933,0.9931713,0.0007119001,0.001216502,0.0003335816,0.000006587473,0.00001678595,0.00001375738,0.00412399],"genre_scores_gemma":[0.005743423,0.9883857,0.0008827157,0.000693141,0.0003359551,0.0000182697,0.00003018833,0.000004309435,0.003906444],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003773393,"threshold_uncertainty_score":0.01262325,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3209015618","doi":"10.2217/fon-2021-1110","title":"The role of Globo H and SSEA-4 in the Development and Progression of Cancer, and their Potential as Therapeutic Targets","year":2021,"lang":"en","type":"review","venue":"Future Oncology","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Office of the Chief Medical Examiner","funders":"","keywords":"Glycosylation; Carcinogenesis; Cell biology; Cancer cell; Ceramide; Glycan; Cancer; Embryonic stem cell; Galectin; Cell; Biology; Biochemistry; Glycoprotein; Apoptosis; Gene; Genetics","authors":[{"name":"Darren Sigal","is_ca":false},{"name":"David J. Hermel","is_ca":false},{"name":"Pei Hsu","is_ca":false},{"name":"Tillman Pearce","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01578068486255948,"gpt":0.3689534633889522,"spread":0.3531727785263928,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003190642,0.0005241772,0.0006891428,0.001558701,0.0002073557,0.0007681341,0.0004300374,0.0007915884,0.002876868],"category_scores_gemma":[0.0003645645,0.0001728161,0.0002855642,0.001633237,0.0003038809,0.0009670781,0.0004747878,0.001181788,0.00159312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000545742,"about_ca_system_score_gemma":0.0008796066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008493856,"about_ca_topic_score_gemma":0.001276676,"domain_scores_codex":[0.9999242,0.00001323635,0.00001029019,0.00001420397,0.00002771596,0.00001032649],"domain_scores_gemma":[0.9998817,0.00004423841,0.00001686706,0.000003959562,0.00003618362,0.00001693355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001062825,0.00006479644,0.0002323142,0.01440933,0.00007965433,0.0003149813,0.00006652759,0.0004550974,0.004384798,0.006621536,0.0261489,0.9471157],"study_design_scores_gemma":[0.00001020633,0.00007581272,0.0007004199,0.001631607,0.00007462831,0.001230188,0.00005225172,0.00007631747,0.0008535063,0.001944326,0.9933373,0.00001347206],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001645525,0.9983584,0.0001097853,0.0002798641,0.0001239554,0.0000027745,0.00001880796,0.000006011294,0.0009357887],"genre_scores_gemma":[0.0005946693,0.9986196,0.0001111555,0.0001056571,0.00006858935,0.000003734468,0.0000256935,9.284794e-7,0.0004700914],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002876868,"threshold_uncertainty_score":0.009624124,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4394942521","doi":"10.2217/fon-2023-0679","title":"Belzutifan: a novel therapeutic for the management of von Hippel–Lindau disease and beyond","year":2024,"lang":"en","type":"review","venue":"Future Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Disease; Clinical trial; Hypoxia-inducible factors; Renal cell carcinoma; Von Hippel–Lindau disease; Bioinformatics; Cancer research; Oncology; Internal medicine; Gene; Biology","authors":[{"name":"Lauren Curry","is_ca":true},{"name":"Maryam Soleimani","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02583162313801747,"gpt":0.3430211738917799,"spread":0.3171895507537625,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003020893,0.0005081015,0.0007292993,0.001741491,0.0002731135,0.0006851357,0.0004987488,0.000716402,0.003501678],"category_scores_gemma":[0.0002957188,0.0001487918,0.000406003,0.001203996,0.00033644,0.00104365,0.0005082955,0.001742411,0.001626117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005562479,"about_ca_system_score_gemma":0.0007201943,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007374658,"about_ca_topic_score_gemma":0.002073802,"domain_scores_codex":[0.9999161,0.00001403367,0.000008962551,0.0000151631,0.00003408606,0.00001166943],"domain_scores_gemma":[0.9999114,0.00003370308,0.00001391105,0.000002677308,0.00002329803,0.00001497856],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008241463,0.00006615214,0.0001377554,0.007869905,0.00006224431,0.0002552157,0.00005395125,0.0002474677,0.002572147,0.004521914,0.0334619,0.9506689],"study_design_scores_gemma":[0.00001538235,0.00008138713,0.000437569,0.00137259,0.00005782561,0.00130416,0.0000311545,0.00006802018,0.0004159162,0.001575756,0.994629,0.00001129831],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001646904,0.997515,0.0001611587,0.000474586,0.0002300156,0.000005324664,0.00002053469,0.00001061036,0.00141814],"genre_scores_gemma":[0.0009358797,0.9973431,0.0002053353,0.0003124728,0.0001627631,0.000006715057,0.0000420591,0.000001836097,0.000989812],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003501678,"threshold_uncertainty_score":0.01171428,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3195219055","doi":"10.2217/fon-2021-0598","title":"Clinical Activity and Safety of the Anti-PD-1 Monoclonal Antibody Dostarlimab for Patients with Recurrent or Advanced dMMR Endometrial Cancer","year":2021,"lang":"en","type":"letter","venue":"Future Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Endometrial cancer; Internal medicine; Regimen; Oncology; Microsatellite instability; Clinical trial; Cancer; DNA mismatch repair; Colorectal cancer","authors":[{"name":"Ana Oaknin","is_ca":false},{"name":"Anna V. Tinker","is_ca":false},{"name":"Lucy Gilbert","is_ca":true},{"name":"Vanessa Samouëlian","is_ca":true},{"name":"Cara Mathews","is_ca":false},{"name":"Jubilee Brown","is_ca":false},{"name":"Maria-Pilar Barretina-Ginesta","is_ca":false},{"name":"Víctor Moreno","is_ca":false},{"name":"Adriano Gravina","is_ca":false},{"name":"Cyril Abdeddaim","is_ca":false},{"name":"Susana Banerjee","is_ca":false},{"name":"Wei Guo","is_ca":false},{"name":"Hadi Danaee","is_ca":false},{"name":"Ellie Im","is_ca":false},{"name":"Renaud Sabatier","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03426658383925036,"gpt":0.3826646853782454,"spread":0.3483981015389951,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008363131,0.0002376883,0.0007153869,0.0001981517,0.000140261,0.0004823952,0.0002229038,0.0004376691,0.004146267],"category_scores_gemma":[0.001453785,0.0001303225,0.0007253772,0.0001985066,0.0002326657,0.0004299396,0.0001580531,0.001074985,0.0005830331],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005511761,"about_ca_system_score_gemma":0.0004365649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002776691,"about_ca_topic_score_gemma":0.001175898,"domain_scores_codex":[0.999738,0.0001359834,0.00002013233,0.00002845147,0.00004944047,0.00002789045],"domain_scores_gemma":[0.9996756,0.0001026491,0.00009938484,0.00001800776,0.0000261843,0.00007809834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2693299,0.005698963,0.0108919,0.003325436,0.001626048,0.0001800924,0.0001261942,0.002002048,0.01064803,0.0008343224,0.01760058,0.6777365],"study_design_scores_gemma":[0.4107063,0.4077544,0.08192235,0.001735949,0.003081776,0.001813365,0.0002275817,0.005185822,0.008444784,0.002478228,0.07654684,0.0001026453],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8950055,0.07690725,0.0006503951,0.002993089,0.0006406693,0.001072347,0.002479512,0.0001513232,0.0200999],"genre_scores_gemma":[0.9813596,0.01066148,0.0006642848,0.001551491,0.0002557539,0.0004387484,0.001502733,0.00001889116,0.003546977],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004146267,"threshold_uncertainty_score":0.01387066,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2127753540","doi":"10.2217/14796694.2.1.15","title":"Dexrazoxane Use In the Prevention of Anthracycline Extravasation Injury","year":2006,"lang":"en","type":"review","venue":"Future Oncology","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Dexrazoxane; Anthracycline; Medicine; Cardiotoxicity; Extravasation; Doxorubicin; Epirubicin; Daunorubicin; Idarubicin; Pharmacology; Chemotherapy; Internal medicine; Pathology; Cancer; Cyclophosphamide; Breast cancer","authors":[{"name":"Brian B. Hasinoff","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06209249161300837,"gpt":0.4201365793525218,"spread":0.3580440877395134,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004047033,0.0005978927,0.001335028,0.002020545,0.0002119858,0.0005014416,0.0007360061,0.0006854603,0.003230789],"category_scores_gemma":[0.0003913394,0.000218757,0.0004403764,0.001789687,0.000233502,0.0006175125,0.0002915443,0.0006725486,0.001601687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000355877,"about_ca_system_score_gemma":0.000541842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008976413,"about_ca_topic_score_gemma":0.001913641,"domain_scores_codex":[0.9998614,0.00002835821,0.00002587562,0.00002408011,0.00004925934,0.00001106521],"domain_scores_gemma":[0.9998394,0.00006369903,0.00003866704,0.00000528693,0.00003900586,0.00001392883],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001923782,0.0001192607,0.0003465511,0.01555482,0.0001097651,0.0004647514,0.00005332978,0.000241525,0.002961478,0.0006428406,0.007555568,0.9717576],"study_design_scores_gemma":[0.0001525226,0.0007573894,0.00572041,0.006411843,0.0005000374,0.009122117,0.0001286872,0.000245235,0.004342598,0.001036738,0.9715512,0.00003129418],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004716427,0.9984341,0.00009022233,0.00006859682,0.00004882303,0.000006165395,0.00001177427,0.000006475157,0.0008620679],"genre_scores_gemma":[0.002115129,0.9969676,0.0001958467,0.00007129245,0.00005115032,0.000007297995,0.00002631725,0.000001273847,0.0005640596],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003230789,"threshold_uncertainty_score":0.01080805,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3159545343","doi":"10.2217/fon-2021-0153","title":"Real-World Genetic Testing Patterns in Metastatic Castration-Resistant Prostate Cancer","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Merck Sharp and Dohme","keywords":"Medicine; FANCA; PALB2; Prostate cancer; Oncology; Genetic testing; Internal medicine; Cancer; DNA repair; Gene; Mutation; Fanconi anemia; Genetics; Germline mutation","authors":[{"name":"Neal D. Shore","is_ca":false},{"name":"Raluca Ionescu‐Ittu","is_ca":true},{"name":"Lingfeng Yang","is_ca":false},{"name":"François Laliberté","is_ca":true},{"name":"Malena Mahendran","is_ca":true},{"name":"Dominique Lejeune","is_ca":true},{"name":"Louise Yu","is_ca":false},{"name":"Joseph E. Burgents","is_ca":false},{"name":"Mei Sheng Duh","is_ca":false},{"name":"Sameer R. Ghate","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0559407481845942,"gpt":0.3889786225716865,"spread":0.3330378743870923,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009569283,0.0001349318,0.0001917784,0.0009750271,0.0002565599,0.0006618709,0.0004716107,0.0004461822,0.002210474],"category_scores_gemma":[0.006168746,0.0001512884,0.000239023,0.001632254,0.000312713,0.0005082887,0.0004940534,0.0004107561,0.0002425273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004343209,"about_ca_system_score_gemma":0.0003830925,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004356759,"about_ca_topic_score_gemma":0.006476633,"domain_scores_codex":[0.9987015,0.0004304581,0.0001905369,0.0003089511,0.0002236282,0.0001450449],"domain_scores_gemma":[0.9927341,0.00172898,0.004465656,0.0002658055,0.0003170918,0.0004883649],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006410092,0.00001206655,0.9984939,0.000008530113,0.00001627821,0.00004802943,0.00003175354,0.00006063672,0.00006373136,0.00001398353,0.00008801581,0.001098999],"study_design_scores_gemma":[0.000002816263,0.00005518482,0.998567,0.000009603925,0.000009531804,0.0005698978,0.0002192129,0.000260913,0.00008479076,0.00003014475,0.0001866611,0.000004169839],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998412,0.0002947352,0.00009390201,0.0001117102,0.000002966479,0.000005511984,0.0007290858,0.000004800161,0.0003451635],"genre_scores_gemma":[0.9994754,0.00006293736,0.00005638753,0.00001738319,0.000003071743,0.000002585486,0.0003492586,0.000001218593,0.00003166935],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004356759,"threshold_uncertainty_score":0.00866282,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4323294773","doi":"10.2217/fon-2022-1059","title":"TRUST-II: a global phase II study of taletrectinib in <i>ROS1</i> -positive non-small-cell lung cancer and other solid tumors","year":2023,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Crizotinib; ROS1; Medicine; Lung cancer; Internal medicine; Oncology; Cancer; Brain metastasis; Clinical trial; Interim analysis; Clinical endpoint; Adverse effect; Adenocarcinoma; Metastasis","authors":[{"name":"Misako Nagasaka","is_ca":false},{"name":"Yuichiro Ohe","is_ca":false},{"name":"Caicun Zhou","is_ca":false},{"name":"Chang‐Min Choi","is_ca":false},{"name":"Nong Yang","is_ca":false},{"name":"Geoffrey Liu","is_ca":true},{"name":"Enriqueta Felip","is_ca":false},{"name":"M. Pérol","is_ca":false},{"name":"Benjamin Besse","is_ca":false},{"name":"Jorgé Nieva","is_ca":false},{"name":"Luis E. Raez","is_ca":false},{"name":"Nathan A. Pennell","is_ca":false},{"name":"Anastasios Dimou","is_ca":false},{"name":"Filippo de Marinis","is_ca":false},{"name":"Fortunato Ciardiello","is_ca":false},{"name":"Takashi Seto","is_ca":false},{"name":"Zheyi Hu","is_ca":false},{"name":"Max Yu-Chen Pan","is_ca":false},{"name":"Weiqing Wang","is_ca":false},{"name":"Shuanglian Li","is_ca":false},{"name":"Sai‐Hong Ignatius Ou","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01232102561456113,"gpt":0.3856566028457878,"spread":0.3733355772312267,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00190756,0.001283991,0.001061038,0.0003617262,0.0002816904,0.0009979488,0.0007195306,0.0009749143,0.003708976],"category_scores_gemma":[0.0006243581,0.000364994,0.001297851,0.000453278,0.0006322598,0.0007684347,0.0007018399,0.001997572,0.0009598041],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001333744,"about_ca_system_score_gemma":0.002014456,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001594408,"about_ca_topic_score_gemma":0.005565062,"domain_scores_codex":[0.9995579,0.000176147,0.00002333755,0.00007407743,0.00004883307,0.000119628],"domain_scores_gemma":[0.9996279,0.00002927239,0.00008863646,0.00002929696,0.0000436449,0.0001811588],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3288563,0.03914946,0.02469399,0.003985295,0.00305172,0.0008660494,0.0006205571,0.009510906,0.3258755,0.002785264,0.03879668,0.2218083],"study_design_scores_gemma":[0.4451852,0.4012955,0.05013498,0.0003239913,0.002438866,0.002725299,0.0003985374,0.004657617,0.04095297,0.001042301,0.05068171,0.000163124],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9570775,0.005914934,0.004232592,0.001745664,0.0002642787,0.009787624,0.008520666,0.0005159252,0.01194097],"genre_scores_gemma":[0.9553458,0.003925161,0.007119439,0.00232659,0.0001395969,0.00652377,0.01681639,0.0002608933,0.00754235],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003708976,"threshold_uncertainty_score":0.01240778,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4224311311","doi":"10.2217/fon-2022-0045","title":"A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ <i>PIK3CA</i> -mutated breast cancer","year":2022,"lang":"en","type":"article","venue":"Future Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Trastuzumab; Medicine; Fulvestrant; Oncology; Internal medicine; Breast cancer; Chemotherapy; Cancer; Estrogen receptor","authors":[{"name":"José Alejandro Pérez Fidalgo","is_ca":false},{"name":"Carmen Criscitiello","is_ca":false},{"name":"Eva Carrasco","is_ca":false},{"name":"Meredith M. Regan","is_ca":false},{"name":"Angelo Di Leo","is_ca":false},{"name":"Karin Ribi","is_ca":false},{"name":"Virginie Adam","is_ca":false},{"name":"Philippe L. Bédard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03373686270539864,"gpt":0.405549785522902,"spread":0.3718129228175033,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001995535,0.001123032,0.001527103,0.000376172,0.0003159419,0.000796053,0.0007182765,0.001061459,0.006000008],"category_scores_gemma":[0.001054963,0.0003403176,0.001172549,0.0002917328,0.0006030641,0.0005150963,0.0003118118,0.002376448,0.001155135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005228945,"about_ca_system_score_gemma":0.001418259,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005890423,"about_ca_topic_score_gemma":0.001460314,"domain_scores_codex":[0.9995798,0.0002538618,0.00001811641,0.00004390772,0.00003967883,0.00006463651],"domain_scores_gemma":[0.9993495,0.0001737799,0.0001278404,0.00004852248,0.00003443269,0.0002659331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8962536,0.0272401,0.001526902,0.0006512636,0.0006214425,0.00009664636,0.00006168643,0.001247954,0.006960901,0.0004893282,0.003697145,0.06115292],"study_design_scores_gemma":[0.8753964,0.1193761,0.001756541,0.00003639279,0.0001785474,0.00006161508,0.00001875251,0.0005915401,0.0006940167,0.0001890982,0.001691143,0.000009646808],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9742171,0.004542431,0.001291985,0.001291127,0.0006172962,0.007855824,0.002457338,0.0002196514,0.007507359],"genre_scores_gemma":[0.9589289,0.004435697,0.005068134,0.003087183,0.0005878846,0.01098853,0.004958808,0.00004946613,0.0118953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006000008,"threshold_uncertainty_score":0.02007204,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3207977249","doi":"10.2217/fon-2021-0753","title":"Alliance A011801 (compassHER2 RD): Postneoadjuvant T-DM1 + Tucatinib/Placebo in Patients with Residual HER2-Positive Invasive Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Placebo; Randomized controlled trial; Cancer; Pathology","authors":[{"name":"Ciara C. O’Sullivan","is_ca":false},{"name":"Karla V. Ballman","is_ca":false},{"name":"Linda McCall","is_ca":false},{"name":"Anuhya Kommalapati","is_ca":false},{"name":"Tyler Zemla","is_ca":false},{"name":"Anna Weiss","is_ca":false},{"name":"Melissa P. Mitchell","is_ca":false},{"name":"Victoria Blinder","is_ca":false},{"name":"Nadine Tung","is_ca":false},{"name":"William Irvin","is_ca":false},{"name":"Myoung-Hee Lee","is_ca":false},{"name":"Matthew P. Goetz","is_ca":false},{"name":"W. Fraser Symmans","is_ca":false},{"name":"Virginia F. Borges","is_ca":false},{"name":"Ian E. Krop","is_ca":false},{"name":"Lisa A. Carey","is_ca":false},{"name":"Ann H. Partridge","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01568102170165933,"gpt":0.3375341293603767,"spread":0.3218531076587174,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001859296,0.00108081,0.001151024,0.0005039789,0.0003663139,0.0008323697,0.0008815226,0.001240834,0.005502533],"category_scores_gemma":[0.0008190473,0.0003737855,0.001071453,0.0005059384,0.0008522543,0.0009195173,0.0005055898,0.002210033,0.0008366411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007919699,"about_ca_system_score_gemma":0.001483269,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007269293,"about_ca_topic_score_gemma":0.003394383,"domain_scores_codex":[0.9994861,0.0002785136,0.0000350325,0.0000807883,0.00004076378,0.00007885875],"domain_scores_gemma":[0.9994746,0.00009315504,0.0001323936,0.00004040726,0.00003101647,0.0002285164],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8872203,0.02901706,0.00185828,0.001077197,0.0006962161,0.00006625697,0.0000799788,0.0009536023,0.0102865,0.0006932502,0.002021275,0.06603006],"study_design_scores_gemma":[0.7266759,0.2650659,0.002495265,0.00006170182,0.0002929206,0.0001024822,0.00004017603,0.0004649059,0.001346724,0.000276603,0.003156781,0.00002076975],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9809977,0.00531772,0.0006964489,0.001141022,0.0004544318,0.005021019,0.00110812,0.0001099873,0.005153496],"genre_scores_gemma":[0.9813228,0.003020786,0.001793038,0.001512677,0.0003882935,0.005066659,0.001580203,0.00002294731,0.005292627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005502533,"threshold_uncertainty_score":0.01840776,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162077153","doi":"10.2217/fon.15.153","title":"Rapid Access Palliative Radiation Therapy Programs: An Efficient Model of Care","year":2015,"lang":"en","type":"review","venue":"Future Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multidisciplinary approach; Palliative care; Narrative review; Radiation therapy; Radiation oncology; Medical physics; Intensive care medicine; Nursing; Internal medicine","authors":[{"name":"Kristopher Dennis","is_ca":true},{"name":"Kelly Linden","is_ca":true},{"name":"Tracy A. Balboni","is_ca":false},{"name":"Edward Chow","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1773303789361742,"gpt":0.4611510236039245,"spread":0.2838206446677503,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001368673,0.0005559771,0.000680891,0.001507634,0.0003672867,0.001877676,0.001148264,0.001484017,0.003395229],"category_scores_gemma":[0.002192945,0.00018178,0.0007034631,0.001411967,0.0006767036,0.001996469,0.001325471,0.001822541,0.001143181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001721847,"about_ca_system_score_gemma":0.003204888,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002301624,"about_ca_topic_score_gemma":0.003667043,"domain_scores_codex":[0.99931,0.0002604362,0.00009427545,0.00007291818,0.0002135487,0.00004882533],"domain_scores_gemma":[0.9992771,0.0003974945,0.0001093535,0.00002327852,0.0001458199,0.00004699848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003362862,0.0001000615,0.0004556995,0.03407267,0.0001381257,0.0001609209,0.0003142186,0.0009398893,0.0005412921,0.03366527,0.02744783,0.9021304],"study_design_scores_gemma":[0.00001362458,0.00008636573,0.0009473056,0.01613233,0.0001234326,0.001198525,0.0002217466,0.0002317471,0.0002278976,0.005115532,0.9756821,0.00001934414],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000470776,0.9877442,0.001361911,0.002941922,0.0002911786,0.00005154304,0.00004609251,0.00002404796,0.007068371],"genre_scores_gemma":[0.004113006,0.9915316,0.002390215,0.0009157166,0.0001786299,0.00004626642,0.00005824533,0.000005785032,0.0007606534],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003395229,"threshold_uncertainty_score":0.0124929,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3133493210","doi":"10.2217/fon-2020-1274","title":"Molecular and Morphological Changes Induced by Ivosidenib Correlate with Efficacy in Mutant- <i>IDH1</i> Cholangiocarcinoma","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Trinity College","funders":"Agios Pharmaceuticals","keywords":"IDH1; Isocitrate dehydrogenase; Medicine; Cancer research; Intrahepatic Cholangiocarcinoma; Downregulation and upregulation; Mutant; Internal medicine; Oncology; Biology; Gene; Enzyme; Genetics","authors":[{"name":"Elia Aguado-Fraile","is_ca":false},{"name":"Anna M. Tassinari","is_ca":false},{"name":"Yuko Ishii","is_ca":false},{"name":"Carlie Sigel","is_ca":false},{"name":"Maeve A. Lowery","is_ca":true},{"name":"Lipika Goyal","is_ca":false},{"name":"Camelia Gliser","is_ca":false},{"name":"Liewen Jiang","is_ca":false},{"name":"Shuchi S. Pandya","is_ca":false},{"name":"Bin Wu","is_ca":false},{"name":"Nabeel Bardeesy","is_ca":false},{"name":"Sung Choe","is_ca":false},{"name":"Vikram Deshpande","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01478920642627858,"gpt":0.2702181729730269,"spread":0.2554289665467483,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001863057,0.0001076789,0.0001541092,0.0002476719,0.00009234175,0.0002116721,0.00008251297,0.0001645516,0.001777307],"category_scores_gemma":[0.0001648342,0.00008006326,0.0001328503,0.0001498555,0.0001551785,0.0001397272,0.00008125134,0.0003193524,0.0002244264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002936042,"about_ca_system_score_gemma":0.0001316284,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004016999,"about_ca_topic_score_gemma":0.0005778738,"domain_scores_codex":[0.9999354,0.00001607359,0.000006267823,0.00001086369,0.0000144123,0.00001697799],"domain_scores_gemma":[0.999836,0.00003459379,0.00005473029,0.00001362021,0.00001734309,0.00004373436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.006172073,0.0003010667,0.02460596,0.00009744208,0.00003788354,0.0002196025,0.00004712516,0.0001679045,0.954329,0.0001076004,0.0002748505,0.01363947],"study_design_scores_gemma":[0.0002872395,0.01026201,0.3359328,0.00002093191,0.0001249735,0.002237034,0.0001619208,0.0009058476,0.64665,0.0001151556,0.003289571,0.00001262461],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972166,0.0009794728,0.0002122165,0.00003158729,0.000005781303,0.0000230331,0.0002279029,0.00002076078,0.001282741],"genre_scores_gemma":[0.9986141,0.0002500353,0.0003070422,0.00001878204,0.000003698321,0.00002241258,0.0002845332,0.000006094494,0.0004933038],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001777307,"threshold_uncertainty_score":0.005945742,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2013307793","doi":"10.2217/14796694.2.5.627","title":"Tumor Dormancy and the Role of Metastasis Suppressor Genes In Regulating Ectopic Growth","year":2006,"lang":"en","type":"review","venue":"Future Oncology","topic":"Mechanisms of cancer metastasis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Metastasis; Ectopic expression; Metastasis suppressor; Suppressor; Dormancy; Metastasis Suppressor Gene; Cancer research; Medicine; Malignancy; Gene; Primary tumor; Cancer; Biology; Oncology; Internal medicine; Genetics; Botany","authors":[{"name":"Benjamin D. Hedley","is_ca":true},{"name":"Alison L. Allan","is_ca":true},{"name":"Ann F. Chambers","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01169550857596107,"gpt":0.2927156381989339,"spread":0.2810201296229728,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002911471,0.000652278,0.0008783655,0.001550087,0.0002775492,0.0007759731,0.0006472551,0.0008351909,0.002416049],"category_scores_gemma":[0.0002656304,0.0002052344,0.0002649126,0.001590793,0.000492501,0.001115157,0.0004057459,0.0009562015,0.003071222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006309809,"about_ca_system_score_gemma":0.0006429792,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007420512,"about_ca_topic_score_gemma":0.001276627,"domain_scores_codex":[0.999905,0.00001521485,0.000009668077,0.00001705509,0.00004206439,0.00001103623],"domain_scores_gemma":[0.9998925,0.00003832005,0.00001903578,0.000004849254,0.00003054686,0.00001477496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007797304,0.00006253062,0.0002332263,0.005929196,0.00003288592,0.000486917,0.00008306927,0.0004553813,0.009529526,0.00814327,0.0174191,0.9575469],"study_design_scores_gemma":[0.00001347036,0.00007651521,0.0008598727,0.0009205216,0.0000301684,0.002152485,0.00005966289,0.00008524311,0.001813482,0.003132875,0.9908437,0.0000119948],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002945389,0.996431,0.0003252962,0.0002004597,0.0001470346,0.000004545765,0.00001068488,0.00001122802,0.002575178],"genre_scores_gemma":[0.001186125,0.9966154,0.0003122302,0.0001031775,0.00007212681,0.00000649085,0.00001810152,0.000001488288,0.001684813],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002416049,"threshold_uncertainty_score":0.008082449,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2000905384","doi":"10.2217/14796694.4.6.779","title":"The Future in Psychosocial Oncology: Screening for Emotional Distress – The Sixth Vital Sign","year":2008,"lang":"en","type":"review","venue":"Future Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Alberta Heritage Foundation for Medical Research; Australian Government","keywords":"Biopsychosocial model; Psychosocial; Medicine; Survivorship curve; Distress; Healthcare system; Health care; Sign (mathematics); Pediatric oncology; Population; Intensive care medicine; Oncology; Psychiatry; Internal medicine; Clinical psychology; Cancer; Environmental health","authors":[{"name":"Bejoy C. Thomas","is_ca":true},{"name":"Barry D. Bultz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04200507105926059,"gpt":0.3883318825882691,"spread":0.3463268115290085,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00202056,0.0007040714,0.001432627,0.00211748,0.0005171916,0.001432187,0.0007858266,0.002142013,0.002118752],"category_scores_gemma":[0.002730602,0.0002466716,0.0004588635,0.001789615,0.001179336,0.003110905,0.001131853,0.00326082,0.001232772],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009384254,"about_ca_system_score_gemma":0.002327508,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001942995,"about_ca_topic_score_gemma":0.003852473,"domain_scores_codex":[0.9992269,0.0003297607,0.00007625866,0.00005747124,0.000267848,0.00004176471],"domain_scores_gemma":[0.9979188,0.00118581,0.0002197821,0.00004481923,0.0004932032,0.0001375982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002807465,0.00004711144,0.000884931,0.005592226,0.00005861983,0.0001986712,0.0001449172,0.0001346486,0.000417041,0.003598235,0.03876342,0.9501321],"study_design_scores_gemma":[0.00003577411,0.0003018051,0.008676503,0.02376951,0.0001762772,0.0078072,0.001551668,0.0004427764,0.0004279965,0.01336432,0.9433551,0.0000910306],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001435787,0.9936764,0.0001707396,0.00439486,0.0006495325,0.000003505123,0.000004632599,0.000006343067,0.0009503841],"genre_scores_gemma":[0.001722703,0.9954212,0.0003980826,0.001315051,0.0007060652,0.000006484272,0.00001071221,0.000001651703,0.0004179299],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002142013,"threshold_uncertainty_score":0.01068586,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2132123971","doi":"10.2217/fon.09.65","title":"Physical Activity, Obesity and Risk for Esophageal Adenocarcinoma","year":2009,"lang":"en","type":"review","venue":"Future Oncology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal University Hospital","funders":"Nova Scotia Health Research Foundation; Saskatchewan Health Research Foundation","keywords":"Medicine; Esophageal adenocarcinoma; Obesity; Physical activity; Esophageal cancer; Internal medicine; Adenocarcinoma; Oncology; Cancer; Physical therapy","authors":[{"name":"Lloyd Balbuena","is_ca":true},{"name":"Alan G. Casson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04542401441194394,"gpt":0.4123853684843281,"spread":0.3669613540723842,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003919788,0.000552643,0.001293337,0.001660896,0.0001644984,0.0005485015,0.0004575235,0.0006460478,0.003249971],"category_scores_gemma":[0.0006255034,0.0002109911,0.0006070255,0.002165044,0.0001696815,0.000409802,0.0003198887,0.0005601499,0.0009659432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002963453,"about_ca_system_score_gemma":0.0008029221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00216592,"about_ca_topic_score_gemma":0.00426205,"domain_scores_codex":[0.9998246,0.00003946965,0.00003293309,0.00002992932,0.00006076775,0.00001238509],"domain_scores_gemma":[0.9998329,0.00007119579,0.00004803393,0.000003142261,0.00003495533,0.000009810848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001977817,0.0001090206,0.002905604,0.03605257,0.0006679967,0.0003947843,0.00008878965,0.0003120128,0.001200121,0.0008184345,0.01222145,0.9450314],"study_design_scores_gemma":[0.0001365642,0.0007713384,0.05531708,0.03803477,0.002988102,0.008430327,0.0004027225,0.0004602772,0.001347631,0.002862641,0.8891779,0.00007067676],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003070495,0.999154,0.00002771897,0.00009663363,0.00003565101,0.000002249563,0.00001171661,0.000001690673,0.0003632257],"genre_scores_gemma":[0.001639135,0.9979076,0.0000845425,0.00004865217,0.00004003965,0.000003673626,0.00002086667,3.205024e-7,0.0002551003],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003249971,"threshold_uncertainty_score":0.01087224,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2138828358","doi":"10.2217/fon.09.119","title":"Nimotuzumab in Pediatric Glioma","year":2009,"lang":"en","type":"review","venue":"Future Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Nimotuzumab; Medicine; Context (archaeology); Glioma; Monoclonal antibody; Epidermal growth factor receptor; In vivo; Oncology; Cancer research; Pharmacology; Internal medicine; Immunology; Receptor; Antibody; Biology","authors":[{"name":"Catherine G. Lam","is_ca":true},{"name":"Éric Bouffet","is_ca":true},{"name":"Ute Bartels","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03178295124147681,"gpt":0.3674432645124994,"spread":0.3356603132710226,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002817304,0.0005350538,0.0008960655,0.001308015,0.0001536645,0.0004283554,0.0003770958,0.0005674831,0.001600807],"category_scores_gemma":[0.0002480604,0.0001447534,0.0002830661,0.001477294,0.0001708496,0.0005163001,0.0003333999,0.0006590475,0.001151837],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005849068,"about_ca_system_score_gemma":0.0006910086,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001155602,"about_ca_topic_score_gemma":0.002491068,"domain_scores_codex":[0.9999038,0.00001989854,0.00001522013,0.00001674901,0.00003540771,0.000008840741],"domain_scores_gemma":[0.9999403,0.00001865158,0.00001627326,0.000001662416,0.00001550068,0.000007572482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001046281,0.00007219082,0.0002360354,0.008819404,0.00006780058,0.0006726385,0.00005299419,0.0002815326,0.002869578,0.001151147,0.01447425,0.9711978],"study_design_scores_gemma":[0.00006379987,0.0002199642,0.002084957,0.002816971,0.0001802234,0.006802046,0.00005583163,0.0001561831,0.001977605,0.001081206,0.9845463,0.00001492795],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003642937,0.9984671,0.00006523946,0.00009484603,0.00006265807,0.000004140717,0.000007088619,0.000004735459,0.0009297642],"genre_scores_gemma":[0.001746975,0.9970715,0.0001898446,0.0001309361,0.00007525751,0.000005987296,0.00002042104,0.000001014508,0.0007580559],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001600807,"threshold_uncertainty_score":0.005355239,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011966810","doi":"10.2217/14796694.3.5.539","title":"Targeting the Rna-Binding Protein Sam68 As A Treatment For Cancer?","year":2007,"lang":"en","type":"review","venue":"Future Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Suppressor; RNA-binding protein; Oncogene; RNA; Biology; Carcinogenesis; Cancer research; Cancer; Breast cancer; Mammary tumor; Haploinsufficiency; Cell biology; Genetics; Gene; Phenotype","authors":[{"name":"Kiven Erique Lukong","is_ca":true},{"name":"Stéphane Richard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05321973433173025,"gpt":0.4203583919596777,"spread":0.3671386576279474,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000600137,0.0008482675,0.001160184,0.001543978,0.000334067,0.000647212,0.0009205851,0.001555644,0.003780052],"category_scores_gemma":[0.0004664811,0.0002258593,0.0003308213,0.001449314,0.0007424374,0.001405671,0.0004336708,0.002124579,0.003970244],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006284832,"about_ca_system_score_gemma":0.000586757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007897708,"about_ca_topic_score_gemma":0.002093347,"domain_scores_codex":[0.99989,0.00002212642,0.00001177382,0.00001962466,0.00004417052,0.00001224877],"domain_scores_gemma":[0.9998158,0.00007812873,0.0000228746,0.00000748924,0.00004782212,0.00002800838],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001658592,0.0001031811,0.0001372224,0.004082612,0.0000678502,0.0003215936,0.00005261053,0.0002978547,0.002579463,0.005050262,0.06695174,0.9201897],"study_design_scores_gemma":[0.00005231569,0.0001207052,0.0004091206,0.0007453546,0.00004398399,0.001288838,0.00004770653,0.00006969969,0.0006021807,0.002173398,0.9944339,0.00001279974],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001690711,0.9969025,0.0001489602,0.0009932658,0.0005297539,0.000004368182,0.000009786591,0.00001075791,0.001231415],"genre_scores_gemma":[0.0008540018,0.9961416,0.0002429629,0.0007404632,0.0004262519,0.000009476315,0.00002136547,0.000002606327,0.001561286],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003780052,"threshold_uncertainty_score":0.0126456,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402838411","doi":"10.1080/14796694.2024.2390821","title":"Barriers and facilitators to next-generation sequencing use in United States oncology settings: a systematic review","year":2024,"lang":"en","type":"review","venue":"Future Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Bayer HealthCare","keywords":"Medicine; Radiation oncology; Oncology; MEDLINE; Family medicine; Medical education; Internal medicine; Radiation therapy","authors":[{"name":"Andrea Ferreira‐Gonzalez","is_ca":false},{"name":"Gilbert Ko","is_ca":false},{"name":"Nicole Fusco","is_ca":false},{"name":"Fiona Stewart","is_ca":false},{"name":"Kristin D. Kistler","is_ca":false},{"name":"Sreevalsa Appukkuttan","is_ca":false},{"name":"Brian Hocum","is_ca":false},{"name":"Stefan Allen","is_ca":false},{"name":"Svetlana Babajanyan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04744542064128006,"gpt":0.3367015373601753,"spread":0.2892561167188953,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01760255,0.00126148,0.005349722,0.008845005,0.0007890185,0.002717243,0.001589588,0.0016927,0.003337389],"category_scores_gemma":[0.07479183,0.001130374,0.005920124,0.009687004,0.0008022296,0.002985373,0.001916829,0.001301756,0.0002741881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00420065,"about_ca_system_score_gemma":0.0243946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01155962,"about_ca_topic_score_gemma":0.03446336,"domain_scores_codex":[0.9859201,0.005998475,0.004511648,0.0007680421,0.002351971,0.0004497123],"domain_scores_gemma":[0.9215848,0.06218168,0.009491854,0.0005742424,0.005512489,0.0006548687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001367309,0.00002113631,0.001477728,0.917892,0.005008896,0.0001032735,0.0007835583,0.0001049115,0.000104152,0.000308073,0.001918781,0.07214084],"study_design_scores_gemma":[0.0001053637,0.0001281539,0.00423355,0.948213,0.02627473,0.0002695625,0.001107636,0.00007971962,0.0001520306,0.0002413982,0.0191593,0.00003556354],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001385273,0.9970682,0.0001687297,0.0005560918,0.00007072536,0.0002544333,0.000200585,0.00000617301,0.0002898482],"genre_scores_gemma":[0.01314122,0.98485,0.0007228065,0.0004805003,0.00003982999,0.0005262558,0.000140346,0.000005027701,0.00009397718],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01760255,"threshold_uncertainty_score":0.09309226,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163739312","doi":"10.2217/fon.14.254","title":"The Role of Oncolytic Virus Immunotherapies to Subvert Cancer Immune Evasion","year":2015,"lang":"en","type":"review","venue":"Future Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Oncolytic virus; Immunotherapy; Cancer immunotherapy; Evasion (ethics); Medicine; Immune system; Virotherapy; Cancer; Cancer treatment; Cancer therapy; Immunology; Immunity; Cancer vaccine; Cancer research; Internal medicine","authors":[{"name":"Samuel T. Workenhe","is_ca":true},{"name":"Meghan L. Verschoor","is_ca":true},{"name":"Karen Mossman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02963852322677003,"gpt":0.3924585436654922,"spread":0.3628200204387221,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004883233,0.0004829844,0.0006933576,0.001479357,0.0002040239,0.0008003066,0.0004957278,0.0008156099,0.001781884],"category_scores_gemma":[0.0003578475,0.0001869019,0.0003224229,0.0009564415,0.0003847718,0.0009163146,0.0004608387,0.001368672,0.0009393915],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005568402,"about_ca_system_score_gemma":0.0006185106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005316749,"about_ca_topic_score_gemma":0.0008679939,"domain_scores_codex":[0.9998939,0.00002269672,0.00001162428,0.00001809936,0.00003932686,0.00001432744],"domain_scores_gemma":[0.9998691,0.00006206669,0.00001863063,0.000005445685,0.00003279443,0.00001201218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007416159,0.0001135227,0.0002041726,0.01224014,0.00008599458,0.0002784713,0.00008520502,0.0008673921,0.01289437,0.0180475,0.01755232,0.9375567],"study_design_scores_gemma":[0.00001291829,0.0001164924,0.0004275758,0.00166504,0.00005618741,0.001010502,0.00004319685,0.0002078158,0.00374938,0.002888326,0.9898049,0.00001766571],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000400742,0.9973476,0.0003942272,0.0002507668,0.0001446387,0.000006295493,0.00001479292,0.000009217127,0.00143167],"genre_scores_gemma":[0.003127735,0.9953575,0.0003977814,0.0001878009,0.00007878972,0.00001070893,0.00002624222,0.000002264233,0.0008111765],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001781884,"threshold_uncertainty_score":0.005961001,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1999540397","doi":"10.2217/fon.14.163","title":"On the Contribution of S100A10 and Annexin A2 to Plasminogen Activation and Oncogenesis: An Enduring Ambiguity","year":2014,"lang":"en","type":"review","venue":"Future Oncology","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Carcinogenesis; Ambiguity; Annexin A2; Cancer research; Annexin; Cancer; Internal medicine; Pathology; Linguistics; Philosophy","authors":[{"name":"Moamen Bydoun","is_ca":true},{"name":"David M. Waisman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02308852363637881,"gpt":0.3250235927638751,"spread":0.3019350691274963,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008120001,0.0006798076,0.001193176,0.002183234,0.0003893673,0.001323511,0.0009611342,0.002168582,0.002393103],"category_scores_gemma":[0.0009238212,0.0003092112,0.0003946887,0.002276988,0.001127048,0.002651048,0.00106026,0.002500671,0.001427765],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008899274,"about_ca_system_score_gemma":0.001346655,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000936306,"about_ca_topic_score_gemma":0.001475979,"domain_scores_codex":[0.9997671,0.00003978186,0.00003183417,0.00004050549,0.00009486623,0.00002593258],"domain_scores_gemma":[0.9994212,0.0003016284,0.00005772743,0.00002049536,0.0001459864,0.0000529364],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000075094,0.00004819887,0.0002336321,0.008200299,0.00006175745,0.0004958932,0.0001678391,0.0004234313,0.002618461,0.01681078,0.02911105,0.9417535],"study_design_scores_gemma":[0.000007924046,0.000047883,0.0005169153,0.001577959,0.00003491568,0.001634602,0.0001048982,0.00008241359,0.0005369492,0.006761238,0.9886785,0.00001581009],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001743649,0.9974735,0.0001934195,0.0009852659,0.0002942224,0.000001626976,0.00000807587,0.000004948606,0.0008644217],"genre_scores_gemma":[0.0007792915,0.9978353,0.0001377321,0.0003429017,0.0003251935,0.000003019343,0.00001499811,0.000001788528,0.0005598183],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002393103,"threshold_uncertainty_score":0.008005679,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4281396346","doi":"10.2217/fon-2021-1629","title":"Targeting <i>FGFR3</i> Alterations with Adjuvant Infigratinib in Invasive Urothelial Carcinoma: the Phase III PROOF 302 Trial","year":2022,"lang":"en","type":"article","venue":"Future Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Helsinn","keywords":"Medicine; Placebo; Clinical endpoint; Tolerability; Metastatic Urothelial Carcinoma; Internal medicine; Oncology; Adjuvant; Bladder cancer; Cisplatin; Urothelial cancer; Urology; Randomized controlled trial; Adverse effect; Urothelial carcinoma; Cancer; Chemotherapy; Pathology","authors":[{"name":"Sumanta K. Pal","is_ca":false},{"name":"Diederik M. Somford","is_ca":false},{"name":"Petros Grivas","is_ca":false},{"name":"Srikala S. Sridhar","is_ca":true},{"name":"Shilpa Gupta","is_ca":false},{"name":"Joaquim Bellmunt","is_ca":false},{"name":"Guru Sonpavde","is_ca":false},{"name":"Mark T. Fleming","is_ca":false},{"name":"Seth P. Lerner","is_ca":false},{"name":"Yohann Loriot","is_ca":false},{"name":"Jean Hoffman‐Censits","is_ca":false},{"name":"Begoña P. Valderrama","is_ca":false},{"name":"Corina Andresen","is_ca":false},{"name":"Marco J. Schnabel","is_ca":false},{"name":"Suzanne Cole","is_ca":false},{"name":"Siamak Daneshmand","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01913689018658343,"gpt":0.3077494896688529,"spread":0.2886125994822695,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001250087,0.001108517,0.001359478,0.0002157078,0.0002664489,0.0008878862,0.0006152311,0.001145081,0.005148259],"category_scores_gemma":[0.000808869,0.0002689563,0.001162821,0.0002509824,0.0005652738,0.0006473656,0.0003217073,0.002148418,0.0009516444],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007127312,"about_ca_system_score_gemma":0.001215272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008050343,"about_ca_topic_score_gemma":0.002379786,"domain_scores_codex":[0.9997534,0.0001168567,0.00001485329,0.00003803345,0.00002983822,0.00004698135],"domain_scores_gemma":[0.9997218,0.00005053459,0.00007723401,0.00002500632,0.00002517801,0.0001002856],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7188585,0.01581025,0.002660011,0.004312626,0.00202077,0.0002184954,0.0002061103,0.002667284,0.05036065,0.001630566,0.02120432,0.1800504],"study_design_scores_gemma":[0.8130772,0.1642653,0.0048481,0.0001546631,0.0006553707,0.0003925523,0.00005564186,0.001240536,0.004232035,0.0007396633,0.01030004,0.00003896245],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9536688,0.01614148,0.002163412,0.003020156,0.0005917864,0.007502061,0.005347783,0.0006055759,0.01095899],"genre_scores_gemma":[0.9678726,0.006650869,0.004046912,0.002709638,0.0002509695,0.005135508,0.006209004,0.0000862872,0.007038099],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005148259,"threshold_uncertainty_score":0.01722264,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131759521","doi":"10.2217/fon.11.134","title":"Oncolytic Viruses: Smart Therapeutics for Smart Cancers","year":2011,"lang":"en","type":"editorial","venue":"Future Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Canada","funders":"","keywords":"Oncolytic virus; Medicine; Cancer research; Cancer; Oncology; Internal medicine","authors":[{"name":"Rebecca C. Auer","is_ca":true},{"name":"John C. Bell","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0324954202615448,"gpt":0.3581239193669639,"spread":0.3256284991054191,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006224002,0.003881828,0.002673302,0.002093565,0.001712636,0.006335231,0.003059605,0.01291306,0.005403263],"category_scores_gemma":[0.008204826,0.001259245,0.002152435,0.0008829365,0.002416983,0.004849495,0.00137945,0.02179918,0.005724585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002529665,"about_ca_system_score_gemma":0.001885885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008923158,"about_ca_topic_score_gemma":0.002798843,"domain_scores_codex":[0.9969084,0.0005307509,0.0003955793,0.0003140594,0.001634019,0.0002171945],"domain_scores_gemma":[0.9932799,0.00312645,0.0003583592,0.0001446805,0.002198337,0.0008923321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007502463,0.00001751096,0.00001683672,0.0003801869,0.00002770244,0.000134131,0.00001674837,0.00005525653,0.0003302072,0.001097562,0.9848955,0.01295342],"study_design_scores_gemma":[0.00004433173,0.00003639811,0.00007860208,0.0001482033,0.00004345181,0.0002857168,0.00001954207,0.0001494927,0.0003698826,0.001068939,0.9977372,0.00001826016],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00005490972,0.02467097,0.0004184722,0.0214568,0.9517366,0.00001931263,0.00003906335,0.00005996221,0.001543954],"genre_scores_gemma":[0.001039116,0.03151026,0.000464204,0.02526063,0.9174908,0.00003114093,0.00005274215,0.00005471767,0.02409638],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.01291306,"threshold_uncertainty_score":0.03291607,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007775064","doi":"10.2217/14796694.1.4.511","title":"Notch Signaling in T-Cell Acute Lymphoblastic Leukemia","year":2005,"lang":"en","type":"review","venue":"Future Oncology","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Chromosomal translocation; Lymphoblastic Leukemia; Leukemia; Gene; Disease; Cancer research; Etiology; Immunology; T cell; Bioinformatics; Biology; Genetics; Internal medicine; Immune system","authors":[{"name":"Andrew P. Weng","is_ca":true},{"name":"Arthur Lau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01258458081867867,"gpt":0.307365435214731,"spread":0.2947808543960523,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004255332,0.0008476462,0.001123399,0.001808365,0.0003099949,0.0008595966,0.0009464677,0.001068702,0.002238022],"category_scores_gemma":[0.0003707881,0.0002704539,0.0002573644,0.002146949,0.0004413236,0.001157618,0.0005487634,0.001347555,0.003885906],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007501577,"about_ca_system_score_gemma":0.0008489075,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001179155,"about_ca_topic_score_gemma":0.002025717,"domain_scores_codex":[0.9998697,0.00002190673,0.00001754579,0.00002395018,0.00005549615,0.00001135059],"domain_scores_gemma":[0.9998753,0.000034642,0.00002308601,0.000005178068,0.00004116358,0.00002066502],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008562598,0.00005893991,0.0001696304,0.005616545,0.0000467206,0.000513263,0.0000497799,0.0005327185,0.002875437,0.003159105,0.03682824,0.950064],"study_design_scores_gemma":[0.00002098834,0.00005528484,0.0005745477,0.001230148,0.00004420527,0.002168744,0.00004657004,0.00008512902,0.0005885352,0.001675368,0.9934973,0.00001326398],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001804501,0.9975216,0.0002360103,0.0002808953,0.0002517776,0.000004198188,0.00001282445,0.0000129156,0.001499395],"genre_scores_gemma":[0.0007229923,0.9976967,0.0002043411,0.0001667616,0.000159686,0.000004760887,0.00002180104,0.000001321332,0.001021659],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002238022,"threshold_uncertainty_score":0.007486999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3156107342","doi":"10.2217/fon-2021-0284","title":"Health-Related Quality of Life and Pain with Selinexor in Patients with Advanced Dedifferentiated Liposarcoma","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Karyopharm Therapeutics","keywords":"Medicine; Quality of life (healthcare); Liposarcoma; Intensive care medicine; MEDLINE; Pathology; Nursing; Sarcoma","authors":[{"name":"Mrinal M. Gounder","is_ca":false},{"name":"Albiruni R. Abdul Razak","is_ca":true},{"name":"Adrienne M. Gilligan","is_ca":false},{"name":"Hoyee Leong","is_ca":false},{"name":"Xiwen Ma","is_ca":false},{"name":"Neeta Somaiah","is_ca":false},{"name":"Sant P. Chawla","is_ca":false},{"name":"Javier Martín‐Broto","is_ca":false},{"name":"Giovanni Grignani","is_ca":false},{"name":"Scott M. Schuetze","is_ca":false},{"name":"Bruno Vincenzi","is_ca":false},{"name":"Andrew J. Wagner","is_ca":false},{"name":"Bartosz Chmielowski","is_ca":false},{"name":"Robin L. Jones","is_ca":false},{"name":"Jatin J. Shah","is_ca":false},{"name":"Sharon Shacham","is_ca":false},{"name":"Michael Kauffman","is_ca":false},{"name":"Richard F. Riedel","is_ca":false},{"name":"Steven Attia","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01391288335984998,"gpt":0.2891460225004868,"spread":0.2752331391406368,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073036,0.000198606,0.0006685759,0.0001473316,0.00008343189,0.0001815875,0.0001055069,0.0001741535,0.001107712],"category_scores_gemma":[0.0007268317,0.00008276144,0.0004208901,0.0001091146,0.0001613531,0.0002961482,0.0001693221,0.0003265849,0.00008177455],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001509403,"about_ca_system_score_gemma":0.0001146571,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001181591,"about_ca_topic_score_gemma":0.0003712453,"domain_scores_codex":[0.9998307,0.00008881268,0.00001692004,0.00001765878,0.00002599545,0.00001984853],"domain_scores_gemma":[0.9997907,0.00008616465,0.0000666534,0.000007870826,0.00001269158,0.00003596888],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.3585259,0.01361751,0.1483575,0.001965382,0.002499674,0.0003608193,0.0005194758,0.004883546,0.05864548,0.0001970442,0.0009860777,0.4094416],"study_design_scores_gemma":[0.04922307,0.4275758,0.5078854,0.0001431352,0.001182722,0.0007843958,0.0003838247,0.003300285,0.007029595,0.0002279844,0.002231111,0.00003262152],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978551,0.001686072,0.00006365986,0.00006402346,0.000009496709,0.00003751199,0.00003806371,0.000003128264,0.00024292],"genre_scores_gemma":[0.9991203,0.0004631482,0.0001246663,0.00004126964,0.00002004143,0.00003748502,0.00005040741,4.05283e-7,0.0001423678],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001107712,"threshold_uncertainty_score":0.00386256,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2955934677","doi":"10.2217/fon-2019-0010","title":"Utilization of Tumor Genomics in Clinical Practice: An International Survey among ASCO Members","year":2019,"lang":"en","type":"article","venue":"Future Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"American Society of Clinical Oncology","keywords":"Medicine; Context (archaeology); Family medicine; Clinical Practice; Clinical trial; Clinical Oncology; Precision medicine; Personalized medicine; Internal medicine; Cancer; Pathology; Bioinformatics","authors":[{"name":"Romualdo Barroso‐Sousa","is_ca":false},{"name":"Hao Guo","is_ca":false},{"name":"Piyush Srivastava","is_ca":false},{"name":"Ted A. James","is_ca":false},{"name":"Walter Birch","is_ca":false},{"name":"Lillian L. Siu","is_ca":true},{"name":"William P. Tew","is_ca":false},{"name":"Sara M. Tolaney","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02515914198445162,"gpt":0.3726269263304013,"spread":0.3474677843459497,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001424809,0.0001186342,0.0001564948,0.0009008873,0.0003313014,0.0005566661,0.0002529052,0.0004657277,0.001496521],"category_scores_gemma":[0.005167618,0.0001712396,0.0001432149,0.001361333,0.0003321891,0.0006366209,0.0005104218,0.0004007705,0.0002506447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004037484,"about_ca_system_score_gemma":0.000520331,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006815183,"about_ca_topic_score_gemma":0.006695346,"domain_scores_codex":[0.9988216,0.0004497542,0.0001680458,0.0001384853,0.0002824834,0.0001398056],"domain_scores_gemma":[0.9930635,0.001653673,0.003576295,0.0001795729,0.000502286,0.001024645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002007245,0.00004023709,0.9969108,0.00001269752,0.000009963948,0.00003312614,0.0007439293,0.0000213044,0.000119193,0.00001036966,0.0001782433,0.001900068],"study_design_scores_gemma":[0.000003003457,0.00008476093,0.9969866,0.00002062181,0.000005754576,0.0001607002,0.002079086,0.0001268392,0.00005564645,0.000008734147,0.000465012,0.00000322507],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984829,0.0001602902,0.00005768946,0.0002469793,0.000003122617,0.00001194876,0.0002657818,0.000002734636,0.0007685691],"genre_scores_gemma":[0.9993332,0.0001685295,0.0000817422,0.0001086909,0.000005369065,0.00001283034,0.0001684266,0.000001611308,0.0001196119],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006815183,"threshold_uncertainty_score":0.01355106,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2167775617","doi":"10.1517/14796694.1.2.149","title":"Zoledronic Acid: Past, Present and Future Roles in Cancer Treatment","year":2005,"lang":"en","type":"review","venue":"Future Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Zoledronic acid; Medicine; Breast cancer; Prostate cancer; Bone resorption; Bone metastasis; Osteoclast; Oncology; Multiple myeloma; Bone Density Conservation Agents; Cancer; Internal medicine; Bone disease; Clinical trial; Osteoporosis; Bone density","authors":[{"name":"Fred Saad","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04450800730881063,"gpt":0.4202681500177839,"spread":0.3757601427089733,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005687629,0.0006677875,0.001439512,0.002232485,0.0003250839,0.001169071,0.000817904,0.001133594,0.003857031],"category_scores_gemma":[0.0005580431,0.0002435426,0.0004167294,0.002832906,0.0006285401,0.001689772,0.0005810241,0.001374163,0.002351242],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008790595,"about_ca_system_score_gemma":0.001271292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001689505,"about_ca_topic_score_gemma":0.003950167,"domain_scores_codex":[0.9998091,0.00003600675,0.00003181745,0.00003102866,0.00007614746,0.00001590726],"domain_scores_gemma":[0.9997767,0.00008430443,0.00004274366,0.000007005114,0.00005850656,0.00003078071],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009096906,0.00005105876,0.0001504019,0.009062743,0.00005278888,0.0002403319,0.00006454482,0.0003386454,0.0009975408,0.003445384,0.02165844,0.9638472],"study_design_scores_gemma":[0.0000374693,0.0001075429,0.0007739369,0.003178656,0.0000791112,0.001570319,0.00008502752,0.0001051208,0.0002212478,0.002397215,0.9914294,0.00001509841],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005987437,0.9991028,0.00004458537,0.0002072385,0.00009357824,0.000001641713,0.000004849567,0.000003396438,0.0004819162],"genre_scores_gemma":[0.000522317,0.9987381,0.0001181773,0.0001350056,0.0001179009,0.00000231594,0.00000848321,5.224497e-7,0.0003572549],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003857031,"threshold_uncertainty_score":0.01290303,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3134053447","doi":"10.2217/fon-2020-1210","title":"Role of Cedazuridine/Decitabine in the Management of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia","year":2021,"lang":"en","type":"review","venue":"Future Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Decitabine; Medicine; Chronic myelomonocytic leukemia; Azacitidine; Myelodysplastic syndromes; Oncology; International Prognostic Scoring System; Internal medicine; Pharmacology; Bone marrow; DNA methylation","authors":[{"name":"Swapna Thota","is_ca":false},{"name":"Aram Oganesian","is_ca":false},{"name":"Mohammad Azab","is_ca":false},{"name":"Elizabeth A. Griffiths","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02505678783195882,"gpt":0.3489397337048004,"spread":0.3238829458728416,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003926988,0.0004777682,0.0009593771,0.001497714,0.0001678256,0.0005519318,0.0005577931,0.0005533667,0.002650532],"category_scores_gemma":[0.0004215012,0.0001565051,0.0004985033,0.001061279,0.000218399,0.0006140668,0.0003913077,0.001204958,0.001100577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003397755,"about_ca_system_score_gemma":0.0005990657,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007176262,"about_ca_topic_score_gemma":0.0016702,"domain_scores_codex":[0.9998761,0.00002720007,0.00002205849,0.00001988046,0.00004300146,0.00001171207],"domain_scores_gemma":[0.999846,0.00007362788,0.00002702408,0.00000420517,0.00003584933,0.00001321337],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001135309,0.00005337472,0.0001117096,0.0146208,0.0001079887,0.0001684419,0.00004499019,0.0003470161,0.001741554,0.001626257,0.01074751,0.9703168],"study_design_scores_gemma":[0.00005566679,0.0002837974,0.001071139,0.005511313,0.0003019265,0.002050494,0.00005231387,0.0001592589,0.0009937159,0.00109138,0.9884106,0.00001827894],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002061352,0.9989232,0.00005781681,0.0001008303,0.00006436788,0.000003846183,0.00001361625,0.000003945542,0.0006261811],"genre_scores_gemma":[0.001052535,0.9982938,0.0001416322,0.0001116823,0.00005048473,0.000004611271,0.00003148444,9.600687e-7,0.0003126642],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002650532,"threshold_uncertainty_score":0.008866906,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3049532301","doi":"10.2217/fon-2020-0573","title":"POLARIS: a Prospective, Multicenter, Noninterventional Study Assessing Palbociclib in Hormone Receptor-Positive Advanced Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Future Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Pfizer","keywords":"Palbociclib; Medicine; Metastatic breast cancer; Oncology; Internal medicine; Clinical trial; Breast cancer; Hormone receptor; Cancer; Clinical Practice; Gynecology; Family medicine","authors":[{"name":"Debasish Tripathy","is_ca":false},{"name":"Joanne L. Blum","is_ca":false},{"name":"Gabrielle B. Rocque","is_ca":false},{"name":"Aditya Bardia","is_ca":false},{"name":"Meghan Karuturi","is_ca":false},{"name":"Joseph C. Cappelleri","is_ca":false},{"name":"Yuan Liu","is_ca":false},{"name":"Zhe Zhang","is_ca":false},{"name":"Keith L. Davis","is_ca":false},{"name":"Yao Wang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.015351142844713,"gpt":0.3512074246991336,"spread":0.3358562818544206,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004428172,0.001279597,0.001212237,0.0004286139,0.0008153547,0.001309559,0.001112317,0.0007541099,0.006321885],"category_scores_gemma":[0.0033415,0.000607294,0.0007225399,0.001172677,0.0009228236,0.0009344923,0.0009245578,0.001766708,0.001690431],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001140258,"about_ca_system_score_gemma":0.003734629,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002285313,"about_ca_topic_score_gemma":0.004777568,"domain_scores_codex":[0.9982539,0.00108696,0.00006930816,0.0002337929,0.0001957623,0.0001603787],"domain_scores_gemma":[0.9974831,0.0004402887,0.0006544938,0.0002004399,0.0003849731,0.0008367416],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7721131,0.02000319,0.1258983,0.002131166,0.002383869,0.0005518982,0.0004970322,0.0007372357,0.008828838,0.002352153,0.02100871,0.04349438],"study_design_scores_gemma":[0.5764498,0.1864408,0.1918999,0.0003663003,0.002907799,0.0008849902,0.0006357574,0.001204642,0.002332548,0.001577182,0.03520009,0.0001001825],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9184882,0.006048754,0.00223102,0.002544367,0.0005204938,0.02800578,0.02283555,0.000159167,0.01916651],"genre_scores_gemma":[0.9183152,0.004002482,0.007097844,0.003097558,0.001173885,0.03766286,0.02111519,0.00008579496,0.007449213],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006321885,"threshold_uncertainty_score":0.02341872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}